Astaxanthin as functional foods for anti-fatigue and anti-obesity by 池内 眞弓
Astaxanthin as functional foods for
anti-fatigue and anti-obesity
学位名 博士（海洋科学）
学位授与機関 東京海洋大学
学位授与年度 2007
URL http://id.nii.ac.jp/1342/00000899/
          DOCTORAL THESIS
ASTAXANTHIN AS FUNCTIONAL FOODS FOR
    ANTI-FATIGUE AND ANTI-OBESITY
March 2008
ttw•-•HIg,}•x,
GRADUATE SCHOOL OF MARINE SCIENCE AND TECHNOLOGY
TOKYO UNIVERSITY OF MARINE SCIENCE AND TECHNOLOGY
  DOCTORAL COURSE OF APPLIED MARINE BIOSCIENCE
              MAYUMIIKEUCHI
ASTAXANTHIN AS FUNCTIONAL FOODS FOR
ANTI--FATIGUE AND ANTIOBESITY
Mayumi Ikeuchi
             Thesis Submitted to
  Tokyo University of Marine Science and Technology
In Panial Fulfi11ment of the Requirements for the Degree of
  Doctor of Philosophy in Applied Marine Bioscience
Laboratory of Nutraceuticals and Functional Foods Science
          Department of Marine Science
  Tokyo University of Marine Science and Technology
2008
                       CONTENTS
CHAPTER 1. General introduction.............................,........... 1
CHAPTER 2. Effects of astaxanthin supplementation on
           exercise-induced fatigue in mice............................ 11
           2-1. Introduction............................................... 12
           2-2. Materials and methods...................................15
           2-3. Results.............,................................,...... 21
           2-4. Discussion.................................................25
CHAPTER 3. Effects of astaxanthin in obese mice fed a high-fat diet.. 38
           3-1. Introduction............................................... 39
           3-2. Materials and methods........................,..........40
           3-3. Results..................................................... 45
           34.Discussion.................................................51
CHAPTER 4. Effects of astaxanthin and exercise; promoting energy
           metabolism and suppressing body fat accumulation
           in mice...........................................................75
           4-1. Introduction............................................... 76
           2-2. Materials and methods.................................. 78
           2-3. Results..................................................... 84
           2-4.Discussion.................................................93
CHAPTER 5. Effects of astaxanthin on lipopolysaccharide-induced
           inflammation in vitro....................................,..... 124
           5-1. Introduction.......................,....................... 125
           5-2. Materials and methods........................,..........127
           5-3. Results.........................................,........... 129
           5-4.Discussion...........................................,.....131
CHAPTER 6. General discussion... ...... ..... .. ......,...
ACKNOWLEDGEMENTS.......... .. . ... ..
REFERENCES........................ ..... ..,.. ... ...
.137
..143
.144
ABBREVIATION
ADL (activities of daily living)
BW (body weight)
CK (creatine kinase)
CS (citrate synthase)
COX (cyclooxygenase)
DMEM (Dulbecco's modified Eagle's medium)
DMSO (dimethyl sulfoxide)
DTNB (5,5'-dithiobis[2-nitrobenzoic acid])
EDTA (ethylenediamine tetraacetic acid)
FBS (fetal bovine serum)
GOT (glutamic oxaloacetic transaminase)
     =AST (aspartate aminotransferase)
GPT (glutamic pyruvic transaminase)
     = ALT (alanine aminotransferase)
GSH (reduced glutathione)
3-HAD (3-hydroxyacyl CoA dehydrogenase)
IKK (inhibitor KB kinase)
IKB (inhibitor KB)
LDL (low density lipoprotein)
L-NAME (N-nitro-L-arginine methyl ester)
MTT (3<4,5-dimethyl-2{hiazolyl)-1,5-diphenyl tetrazolium bromide)
MDH (malate dehydrogenase)
NADH (reduced nicotinamide adenine dinucleotide)
NEFA (non esterified fatty acid)
NF-KB (nuclear factor KB)
NO (nitric oxide)
NOS (nitric oxide synthase)
PGE2 (prostaglandin E2)
QOL (quality of life)
RER (respiratory exchange ratio)
ROSs (reactive oxygen species)
SDH (succinate dehydrogenase)
TC (total choiesterol)
TCA cycle (tricarboxylic acid cycle)
TG (triglyceride)
TNF-oc (tumor necrosis factor-oc)
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Astaxanthin as functional foods for anti-fati ue and anti-obesit
Astaxanthin is a natural antioxidant carotenoid that occurs in a wide variety of
living organisms. The present study was designed to determine the effect of
astaxanthin on endurance capacity in mice. And we investigated the effects of
astaxanthin supplementation in obese mice fed a high-fat diet.
Experiment 1. Effects of astaxanthin supplementation on exerciseinduced
fatigue in mice. Mice were given orally either vehicle or astaxanthin by stomach
intubation for 5 weeks. The astaxanthin group showed a significant increase in
swimming time to exhaustion as compared to the control group. Blood lactate
concentration in the astaxanthin groups was significantly lower than in the control
group. In the control group, plasma non-esterfied fatty acid (NEFA) and plasma
glucose were decreased by swimming exercise, but in the astaxanthin group, NEFA
and plasma glucose were significantly higher than in the control group.
Astaxanthin treatment also significantly decreased fat accumulation. These results
suggest that improvement in swimming endurance by the administration of
astaxanthin is caused by an increase in utilization of fatty acids as an energy
source.
Experiment 2. Effects of astaxanthin in obese mice fed a hightat diet.
Astaxanthin inhibited the increases in body weight and weight of adipose tissue
that result from feeding a high-fat diet. In addition, astaxanthin reduced liver
weight, liver triglyceride, plasma triglyceride, and total cholesterol. Moreover,
astaxanthin inhibited reduction in adiponectine.
Experiment 3. Effects of astaxanthin and exercise, promoting energy
metabolism and suppressing body fat accumulation. Astaxanthin prevents the
obesity from high-fat diet and more, is heightened by combination with exercise.
Experiment 4. Effects of astaxanthin and exercise on mitochondrial enzymes
in mice. Astaxanthin were elevated mitochondrial enzyme activities. Moreover,
mitochondrial enzyme activities were more increased by combination of
astaxanthin and exercise.
These results suggest that astaxanthin may be of value in reducing the likelihood of
obesity and metabolic syndrome in affluent societies.
  CHAPTER 1
General introduction
1
CHAPTERI. Generalintroduction.
     Recently, in Japan, the development of symptoms rate of lifestyle
related diseases are increasing. These include of diabetes, hyperlipemia, high
blood pressure, obesity and so on. It is certain that the disorder of eating
habits becomes the main cause and other factors follow such as deviation of
nutrition, lack of exercise, smoking, drinking, stress and others. In Japan, the
deviation of nutrition has become a big problem, because economy became
strong and we living satiation environment. We tend to eat western food and
junk food.
     It is thought that the increase of the lifestyle related diseases is a big
problem for the aging society on various aspects such as welfare, economic
and medical fields. In order to solve the problem, first of all, eating habits
should be improved and it should improve, yet probably it will be quite
difficult to eat three times per day with good nutrition balance. There are'few
people who actually eat "30 food items per day". That is why, health food and
dietary supplement as preventive medical food become effective. The
supplement plays two roles. First role is to prevent through advanced
maintenance illness using more advanced maintenance and improvement of
health, and physiology activity of food composition. The second role is
supplementing the nutrition. Different kind of dietary supplements are on the
market and penetrate in our society. Thus, in addition to fu1fi11 nutrition
(primary function of food), and palatability (secondary function of food), the
thirdly function of food which for health, is strongly required for foods.
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1-1. Necessary condition of functional foods.
     All foods are functional to some extent because all foods provide taste,
aroma and nutritive value. However, foods are now being examined
intensively for add physiologic benefits, which may reduce chronic disease
risk or otherwise optimize health. It is these research efforts that have led to
the global interest in the growing food category now recognized as
"functional foods". Functional foods have no universally accepted definition.
The concept was developed in Japan in the 1980s when, faced with escalating
health care costs, the Ministry of Health, Labour and Welfare initiated a
regulatory system to approve certain foods with documented health benefits in
hopes of improving the health of nation's aging population. These foods,
which are eligible to bear a special seal, are now recognized as the Food for
Specified Health Use. As of July 2002, nearly 300 food products had been
granted the Food for Specified Health Use status in Japan. Several factors are
responsible for the fact that this is one of the most active areas of researc'h in
the nutrition sciences today: 1) an emphasis in nutritional and medical
research on associations between diet and dietary constituents and health
benefits, 2) a favorable regulatory environment, 3) the consumer selfÅíare
phenomenon, and 4) rapid growth in the market for health and wellness
products.
     Health food, so called functional food, is also important in maintenance
of the preventive medicine as future medical treatment and human health.
Historically the education enlightenment or cognition of the health foods were
not always appropriate. Today, many people think that health food is doubtfu1.
0n the other hand, there are many people who feel supported by functional
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food. Since companys seek profit they neglect safety and distribute their
goods on the market. And it is a fact that the image of health food worsens
whenever negative reports on consumers, violations of the Pharmaceutical
Affairs Law, and illegal business practices are raised on the news. However,
functional foods are usefu1, and important for humans as preventive medicine.
I think that a functional food must be widely understood from the aspect of
the preventive medicine in order to protect ourselves. In modern society,
functional food should be taken in our daily life. There are three requirements
for functional food. First, it must be evidence-based. Second, it is safe. Third,
the mechanisms must be solved or presumed. The above three points are
necessary conditions.
1-2. Function of functional foods.
     The function of functional foods, becomes to prevent an obstacle for the
human body, brain, and it's mental health. No matter which healthy stage it is.
The functional foods has a role not only of curing disease and disability but
also in improving health and beauty, as well as improving endurance. Various
ingredients of functional foods work for eliminating active oxygen produced
by aging or stress, maintaining and improving brain function and preventing
metabolic syndrome.
     These "prevention functions" and "improvement functions" are
expected not only in pharmaceutical products but also in functional foods.
4
1-3. Importance of exercise and nutrition.
     Aging society is enhanced, and the number of care authorization
persons in our country is over 4,300,OOO people in March, 2006. In order to
maintain activities of daily living (ADL), the role of exercise became the
remarkable important point, administratively from the view point of
preventing care. The decline of motor function causes falling down and
fracture. Moreover, decline of motor function occurs not only by osteoporosis
and muscle atrophy but also through decline of muscular metabolism from
aging. The decline of the metabolism of skeletal muscle may induce
accumulation ofbody fat, the decline ofinsulin susceptibility, and may lead to
development of symptoms of metabolic syndrome. Since aging causes decline
of motor function, quality of life (QOL), and healthy life expectancy, it is
important to prevent it through antiaging effects. In order to maintain and
raise a motor function, the amount of body activities is required, energy
consumption is made active or it becomes important to apply load to skeletal
muscle and to maintain muscular power. Moreover, not only exercise but
nutrMon ls lmportant.
     Generally, the nutrition for a sport is in the tendency considered to be
taking in the specific food and specific drink for demonstrating excellent
performance for the athlete. However, for civilians to acquire physical
strength and the exercise, carrying out suitable nutrition ingestion with
exercise is recommended. Although various functional foods have enlivened
the market now, it is not said that what is necessary is merely to take in
specific functional foods. It cannot be said as the essence of measuring
nutrition. According to each individual's life style, it is being daily living
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and important in exercise, nutrition, and rest three rapid elements whether it
can routlmze.
     Appropriate nutrition is essential for proper performance of exercise. In
particular, correct nutrition is critically important for improvement of athletic
performance, conditioning, recovery from fatigue after exercise, and
avoidance of injury. Although athletes need to eat a well-balanced basic diet,
there are several nutritional factors that are difficult to obtain at a sufficient
level from a normal diet since athletes require more nutrients than the
recommended daily allowances. Thus, nutritional supplements (functional
foods) containing carbohydrates, proteins, vitamins, and minerals have been
widely used in various sporting fields, partly because these functional foods
are easily taken before, during, and/or after exercise. Several natural food
components have also been shown to exert physiological effects, and some of
them are considered to be usefu1 for improving athletic performance or for
avoiding the disturbance of homeostasis by strenuous exercise.
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Fig. 1. Astaxanthin
     Astaxanthin (Fig. 1) is a pigment that belongs to the family of the
xanthophylls, the oxygenated derivatives of carotenoids whose synthesis in
plants derives from lycopene. Astaxanthin is one of the main carotenoid
pigment found in aquatic animals and is included in many well--known
seafoods such as salmon, trout, red seabream, shrimp, lobster, and fish eggs
(1). The use of astaxanthin in the aquaculture industry is important from the
standpoint of pigmentation and consumer appeal but also as an essential
nutritional component for adequate growth and reproduction. In addition, one
of the most important properties of astaxanthin is its antioxidant properties
which has been reported to surpass those of 6tarotene or even a{ocopherol
(2). It has many highly potent pharmacological activities, such as
antioxidative activity (3-6), antitumor and antiÅíancer effects (7), and
anti-diabetic (89) and anti-inflammatory actions (10-1 1).
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     Some microorganisms are rich in astaxanthin, the Chlorophyte alga
Haematococcus pluvialis is believed to accumulate the highest levels of
astaxanthin in nature. Commercially grown Haematococcus pluvialis can
accumulate > 30g ofastaxanthin kg dry biomass (12).
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1-5. 0bject of this study.
       In modern society, many people feel fatigue causes various health
problems. We feel fatigue and daily feebleness, and this causes disorder of
homeostasis in the body. However, the molecular and neuronal mechanisms
of fatigue still remain unclear. Fatigue is divided into two kinds according to
manner in which it is manifested, physical fatigue and psychological fatigue.
Physical fatigue is divided into peripheral fatigue (peripheral muscle fatigue)
and central nervous system fatigue. Muscle fatigue is caused by exercise that
activates the physical energy metabolism. Muscle fatigue is induced by
decrease of energy sources in skeletal muscle and an accumulation of contain
products that are increased by exercise. On the other hand, central nervous
system fatigue is caused by decrease of blood glucose and the production of
fatigue-products in the brain. These types of fatigue can be prevented and one
can recover from them by taking certain nutrient. Fatiguefelated research
generally includes an examination of treatments that delay the occurrenc'e of
fatigue and enhance physical performance. This often involves nutritional
strategies that supply extra fuel to the working muscle, or buffer the buildup
of toxic metabolic byproducts. I think that it is "making fatigue hard to
cause" equal to "improvement endurance capacity".
     During in vivo screening for endurance capacity and anti-fatigue foods,
I observed salmon. A salmon ascends a river for laying eggs. What the
strength of salmon based on? I thought that relation would be in the
astaxanthin which is the antioxidants contained in a salmon. And astaxanthin
was found to have a potent enhancing effect on endurance capacity. Moreover,
I found that astaxanthin inhibits the elevations in body weight and adipose
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tissue weight caused by a high-fat diet. The present study aimed to c}arify the
manner of this effect.
     This study was designed to examine astaxanthin as functional foods for
anti-fatigue and anti-obesity. The outline of this experiment is shown below.
1) Effects of astaxanthin supplementation on exercise-induced fatigue in
  mlce.
2) Effects of astaxanthin in obese mice fed a high-fat diet.
3) Effects of astaxanthin and exercise; promoting energy metabolism and
  suppressing body fat accumulation in mice.
4) Effects of astaxanthin and exercise on mitochondrial enzymes in mice.
5) Effects of astaxanthin on lipopolysaccharide- induced inflammation in
  vitro.
10
           CHAPTER2
Effects of astaxanthin supplementation on
   exerciseinduced fatigue in mice.
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CHAPTER 2. Effects of astaxanthin supplementation on
exerciseinduced fatigue in mice.
2-1. Introduction.
     In modern society, many people feel fatigue in various health problems.
We feel fatigue and feebleness daily, and this causes disorder of homeostasis
in the body. Fatigue has the two types which are mutually connected. The first
is physical fatigue by energy metabolism, and the second is mental fatigue
from psychological factor. The definition and concept are also various.
According to medical dictionary (13) "The state following a period of mental
or bodily activity characterized by a lessened capacity for work and reduced
efficiency of accomplishment, usually accompanied by a feeling of weariness,
sleepiness, or irritability; it may also supervene when from any cause energy
expenditure outstrips restorative processes; e.g., lack of sleep or food.
Sensation ofboredom and lassitude due to absence of stimulation, monotony,
or lack of interest in one's surroundings. Fatigue may be purely physical and
confined to a single organ; e.g., of muscles or gland after a period of
prolonged activity." Also in the medical dictionary, it states that fatigue is an
objective physiological phenomenon, at the same time, the subjective
consciousness. Thus, the word "fatigue" is ambiguous and unclear. Therefore,
though fatigue is one of the important body signs, biological research has not
been advanced until now. However, in recent years, the research for the
elucidation of the mechanism of fatigue has begn progressively conducted.
Simultaneously, research of a new effective food material for fatigue has been
conducted. The exact definitions of "endurance capacity" and "anti-fatigue"
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are not clear. However, anti-fatigue has a range of meaning as follows; to
improve athletic abilities and recover from fatigue for athletes, and ease
fatigue in daily life and at work for ordinary people. Not only activity of the
physical body but also mental problem causes fatigue in the body. For
example, human's brain is feel tiredness in a mental strain state such as human
relationship at work, the pressure of work, and family matter. The mental
fatigue appears not only mentally but also physically. And the symptom
resembles physical fatigue. Moreover, since mental changes is difficult to
recognize it is likely to over look the mental fatigue and we just focus on
physical conditions. Physical fatigue is accumulation of daily fatigue, and it
happens from thirties to fonies in many cases, but the cause of "mental
fatigue" exists regardless of age. It is not rare for the children who feel the
stress of taking an examination or school life and lapse into "mental fatigue".
When children say, "I'm tired", and they look languid, it is important to
suspect "mental fatigue". Since a cause differs between physical fatigue and
mental fatigue, the medical treatment methods differ. If the symptoms of
fatigue has occur, it is required to explore the cause from both physical sides
and mental sides of the physical and the mental.
     To date, behavioral pharmacological research has been performed for
anti-fatigue. However, at present, the method of quantifying fatigue is not yet
established and the mechanism of fatigue is also not clear. Exercise-induced
fatigue has been attributed to the following factors. First, myoglobin and an
energy metabolic system coenzyme leak out into the blood from cells and
tissues damaged by exercise, and destruction of red blood cells occurs.
Second, exercise promotes consumption of energy sources such as glycogen
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by mobilizing internal energy metabolism to the maximum and using and
depleting the energy source. Third, through these processes, exercise causes
the production and accumulation of products of metabolism, such as lactic
acid, in the body. Therefore, recovery from exercise fatigue requires repair-of
the damage that has occurred in the body. Specifically, resynthesize of the
leaked cell and tissue components and consumed energy sources are needed,
as decomposition and removal of accumulated byproducts of metabolism.
Thus, it is considered to lead to anti-fatigue to recover the damage produced
in the body at an early stage, or to minimize the damage produced in the body.
Therefore, it can be said that anti-fatigue function is promotes recovery from
fatigue or effect which make fatigue hard to cause. We think that it is "making
fatigue hard to cause" equal to "improvement endurance capacity".
     During in vivo screening for endurance capacity and anti-fatigue foods,
astaxanthin was found to have a potent enhancing effect on endurance
                                    'capacity in mice. The present study aimed to clarify the manner of this effect.
14
2-2. Materials and methods.
2-2-1. Materials.
     The astaxanthin used in this study was Asta REAL 50F, supplied by
Fuji Chemical Industry Co., Ltd, Toyama, Japan. Vitamin E
(DL-oetocopherol), vitamin C (ascorbic acid) and fi-carotene were purchased
from Wako Pure Chemical Industries, Ltd, Japan.
2-2-2. Animals.
     Four-week-old male Std: ddY mice (SLC, Japan) were used. They were
housed in standard cages (21.5Å~32Å~14 cm, 5 mice/cage) under controlled
conditions of temperature (24Å}10C), humidity (50Å}29o), and lighting (lights
on from 08:OO to 20:OO). They were provided a normal diet (MR stock,
NIHON NOUSAN, Japan) and water ad libitum.
     Animal studies were performed according to the regulations of'our
laboratory in line with the 1980 guideline Notification No. 6 of the Prime
Minister's Office ofJapan.
2-2-3. Highintensity load swimming test (Experiment 1).
     The mice were allowed to adapt to the laboratory housing for at least 1
week. Forty mice were divided into four groups (n =10 per group). The mice
were given either vehicle (olive oil) or astaxanthin in doses of 1.2, 6, and 30
mg/kg body weight by stomach intubation at 17:OO, 5 days a week for 5
weeks. Samples were administrated in a volume of 200 ptL. The mice were
submitted to weekly swimming exercise supporting constant loads (lead fish
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sinkers, attached to the tail) corresponding to 109o of their body weight. The
mice were assessed to be fatigued when they failed to rise to the surface of the
water to breathe within 5 seconds (14). The swimming exercise was carried
out in a tank (28Å~46Å~29 cm), fi11ed with water to 26 cm depth and maintained
at a temperature of 28Å}10C. To avoid circadian variations in physical activity,
swimming exercise was performed between 10:OO and 17:OO, a period during
which minimal variation of endurance capacity has been confirmed in rats
(15).
2-24. Middle-ntensity Ioad swimming test (Experiment 2).
     The mice were given either vehicle (olive oil), or astaxanthin in doses
of 1.2, 6, and 30 mg/kg body weight (n =10 per group) by stomach intubation
5 days a week for 3 weeks. Each of the mice had a weight attached (5 9o body
weight) to the tail for the duration of the swimto-exhaustion exercise. The
mice were assessed to be fatigued when they failed to rise to the surface of the
water to breathe within 5 seconds.
2-2-5. Effects of astaxanthin supplementation on exerciseinduced fatigue
(Experiment 3).
     The mice were allowed to adapt to the laboratory housing for at least 1
week. Forty mice were divided into four groups (n =10 per group)..The mice
were given either vehicle (olive oil) or astaxanthin in doses of 1.2, 6, and 30
mg/kg body weight by stomach intubation at 17:OO, 7 days a week for 5
weeks. Exercise induced fatigue of the mice were performed using a treadmi11,
With the aim of accustom to treadmi11, the mice were performed treadmi11
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with a constant speed (20 mlmin) for 15 min at 11:OO to 17:OO everyday from
4 weeks after. After 5 weeks, the mice were performed using treadmi11 with a
constant speed (25 m/min) for 1 hour. And then, each of the mice had a
weight attached (59o body weight) to the tail for the duration of the
swimtoÅíxhaustion exercise.
2-2-6. Biochemical assay (Experiment 4).
     The protocol was the same as above except that the mice were made to
swim for a predetermined length of time (15 min) supponing loads
corresponding to 5 9o of their body weight. Blood samples for lactate, glucose,
and non-esterified fatty acid (NEFA) determinations were collected 7 times
from the tail before the beginning and at 5-min intervals during swimming
exercise, as well as 10, 30, and 60 min after exercise. To avoid blood dilution
with residual water at the tail of the animal, the mice were quickly dried with
a towel immediately before blood collection. The mice were immedia' tely
returned to the tank after blood sampling. Lactic acid concentration was
determined with a Kyowa Medix commercial kit (Determiner LA, Tokyo,
Japan). NEFA was measured by the acyl-CoA synthetase and acyl-CoA
oxidase enzyme method with a commercial kit (NEFA Ctest Wako, Wako
Pure Chemical Industries, Osaka, Japan). Glucose was assayed by a
combination of mutase and glucose oxidase with a commercial kit (Glucose
CII test Wako).
     The following week, these groups were further subdivided into
non-exercise and exercise groups. Exercise groups were made to swim for 15
min supporting loads corresponding to 59o of their body weight, and
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immediately after swimming were killed by dislocation of the neck. Blood
samples for creatine kinase (CK) activity were taken from the heart. Plasma
samples were refrigerated until assay, and CK activity was measured using a
commercial kit (CPK II test Wako). Epididymal adipose tissue and organs
(liver, kidney, spleen, heart and muscle) were quickly removed and weighed.
Liver and muscle samples from mice in both groups were removed and stored
at -800C, and glycogen content was determined using the method of Lo et al
(16). Briefly, the samples were incubated in 309o KOH saturated with Na2S04
until homogeneous solution was obtained. After cooling the solution to room
temperature, 959o ethanol was added into tubes to precipitate the glycogen
from the alkaline digestate. The tubes were kept on ice for 30 min, then they
were centrifuged (1,OOO Å~ g, 20 min) and supernatant was aspirated. The
glycogen pellet was dissolved in distilled water. To 1 ml aliquot of glycogen
solution, 1 mi of59o phenol solution was added and subsequently also 5 ml of
969o H2S04. The tubes were allowed to stand for 10 min, then, they Were
shaken and placed for 25 min in water bath at 250C. The absorbance of the
phenolsulfuric acid reaction product from glycogen was read on a
spectrophotometer at 490 nm against a blank prepared by using 1 mi of water
instead of glycogen solution.
2--2-7. Effects of astaxanthin on the respiratory exchange ratio in
(Experiment 5).
     Fifty mice were divided into four groups (n ==10, 12). The mice
given either vehicle or astaxanthin in doses of 1.2, 6 and 30 mg/kg
weight by stomach intubation at every day for 6 weeks.
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mice
were
body
     A 10-lane motorized rodent treadmi11 (Muromachi Kikai, Tokyo, Japan)
was used to exercise. The mice ware run on a treadmi11 at an inclination of OO
and underwent a 3 times a week for 6 weeks running program to enable them
run 20 m/min for 40 min as follows: lst week: 10 min; 2nd week: 20 min; 3rd
week: 30 min; 4th week: 40 min; 5th week 40 min. The following week, the
mice were deprived of food overnight. And then, they were placed in a
treadmill chamber and allowed to rest for 30 min. They were then made to run
at speed of 20 m/min for 40 min, during which the respiratory gas was
monitored.
     The instruments used for the measurement of respiratory quotient in
mice consisted of acrylic metabolic chambers, gas analyzers (model LE 405
GAS ANALYZER, Panlab Technology for Bioresearch, Spain), and a
switching system (model LE 400 AIR SUPPLY AND SWITCHINq Panlab
Technology for Bioresearch, Spain).
2-2-8. Effects of antioxidants on swimming exercise in mice (Experiment
6).
     Fifty mice were divided into five groups (n =10 per group).The mice
were given either vehicle, astaxanthin in doses of 30 mg/kg, 6Åíarotene 30
mg/kg, vitamin E 100 mg/kg and vitamin C 100 mg/kg body weight by
stomach intubation 5 days a week for 6 weeks. Each of the mice had a weight
attached (79o body weight) to the tail for the duration of the
swimto-exhaustion exercise. The mice were assessed to be fatigued when
they failed to rise to the surface of the water to breathe within 5 seconds.
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2-2-9. Statistical analysis.
     Data are expressed as mean Å} SE. Comparisons of swimming capacity
between control and treated groups were assessed using one-way analysis of
variance (ANOVA) and the Tukey Multiple Comparison Test. The data on
metabolic parameters were analyzed by the unpaired t test. The data on
glycogen concentration were assessed using two-way analysis of variance
(ANOVA)' followed by Fisher PLSD post-hoc analysis. A level ofp < O.05
was used as the criterion for statistical significance.
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2-3. Results.
2-3-1. Effects of astaxanthin on swimming exercise (Experiment 1, 2).
     In Experiment 1, which involved a 109o body weight load, the 6 mg/kg
and 30 mg/kg astaxanthin groups showed a significant increase in swimming
time to exhaustion as compared to the control group from the first week. In
the 1.2 mg/kg astaxanthin group, a significant increase in swimming time to
exhaustion as compared to the control group was evident after 5 weeks (Fig.
2-1).
     In order to investigate in detail, the mice had a weight attached 5 %
body weight for the duration of the swim{oÅíxhaustion. With a 59o body
weight load, the mice in the astaxanthin groups again swam for significantly
longer times compared to the control group (Fig. 2-2).
2-3-2. Effects of astaxanthin supplementation on exerciseinduced fatigue
(Experiment 3).
     Exercise induced fatigue of the mice were performed using a treadmi11.
The mice were performed using treadmi11 with a constant speed (25 m/min)
for 1 hour. And then, each of the mice had a weight attached (59o body
weight) to the tail for the duration of the swimto-exhaustion exercise. The
mice in the astaxanthin 6 and 30 mg/kg groups again swam for significantly
longer times compared to the control group (Fig. 2-3).
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2-3-3. Effects of astaxanthin on blood lactate, glucose, and NEFA
concentration during swimming (Experiment 4).
     In the astaxanthin groups, blood lactate concentration was significantly
lower than in the control group (Fig. 2-4).
In the control group, plasma glucose was decreased by 15 min of swimming
exercise. After the exercise ended, the plasma glucose recovered. However, in
the astaxanthin 6 mg/kg, 30 mg/kg groups, plasma glucose was significantly
higher than in the control group. In the control group, plasma NEFA
concentration was decreased by 15 min of swimming exercise. In the
astaxanthin 30 mg/kg group, plasma NEFA was significantly increased by
swlmrnlng exerclse.
2-3-4. Effects of astaxanthin on epididymal adipose tissue weight
(Experiment 4).
     There was no significant difference in body weight between the control
group and astaxanthin groups for 5 weeks (control: 42.1Å}1.0 g, astaxanthin
1.2 mg/kg: 42.9Å}1.1 g, 6 mg/kg: 42.3Å}1.2 g, 30 mg/kg: 42.3Å}1.2 g). But in
the 30 mg/kg astaxanthin group, epididymal adipose tissue weight was
significantly (p < O.05) decreased compared to that of the control group (Fig.
2--5). In the astaxanthin 1.2 mg/kg and 6 mg/kg groups, the epididymal
adipose tissue weight tended to be lower than in the control group, but not
significantly.
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2-3-5. Effects of astaxanthin on liver and muscle glycogen (Experiment
4).
     No-exercise, astaxanthin had no effect on glycogen concentration in the
liver and gastrocnemius muscle. Liver glycogen contents were decreased by
swimming exercise. However, liver glycogen contents were significantly
higher in the astaxanthin 30 mg/kg groups than in the control group after
swimming for 15 min (Fig. 2-6). In the astaxanthin 6 mg/kg and 30 mg/kg
groups gastrocnemius muscle glycogen contents tended to decrease, but not
significantly. And, gastrocnemius muscle glycogen contents significantly
higher in the astaxanthin 6 mg/kg and 30 mg/kg groups than in the control
group after swimming for 15 min.
2-3-6. Effects of astaxanthin on plasma CK activity (Experiment 4).
     Plasma CK activity was increased by exercise. But increased was
reduced in the astaxanthin 30 mg/kg group (Fig. 2-7).
2-3-7. Effects of astaxanthin on respiratory exchange ratio in mice
(Experiment 5).
     The vehicle or astaxanthin was administered 6 weeks. Figure 2-8 shows
the respiratory exchange ratio (RER) in mice on before exercise and during
exercise. The control group maintained RER at O.90-O.98 before exercise and
RER values were lowered by exercise. The astaxanthin 6 mg/kg and 30 mg/kg
groups, before exercise were tended to be lower than in the control group.
Furthermore, the astaxanthin 6 mg/kg and 30 mg/kg groups, during exercise
RER values were lower than in the control group.
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2-3-8. Effects of antioxidants on swimming exercise in mice (Experiment
6).
     In experiment 6, which involved a 7 9o body weight load, the 30 mg/kg
astaxanthin groups showed a significant increase in swimming time to
exhaustion as compared to the control group from the second week (Fig. 2-9).
However, in the fi-carotene, vitamin E and vitamin C groups, similar results
were not obtained.
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2-4. Discussion.
     Many aspects of fatigue have been studied over the years, but adequate
methods for objective evaluation of fatigue have not yet been established. In
the present study, male mice exercised to fatigue, and the effect of astaxanthin
supplementation on endurance capacity and fatigue was evaluated. Swimming
time was significantly prolonged by administering astaxanthin (Fig. 2-1, 2-2,
2-3, 2-9). The present study aimed to clarify this effect.
     In the control group, plasma glucose was decreased by swimming
exercise. In the astaxanthin groups, plasma glucose was significantly higher
than in the control group (Fig. 2-4b). In addition, liver and muscle glycogen
contents were significantly higher in the astaxanthin groups than in the
control group after swimming for 15 min (Fig. 2-6). These results indicate
that the supply of glucose can be used more smoothly andlor that glucose
utilization may be decreased during exercise in the astaxanthin. The
glycogensparing effect of astaxanthin could provide an important survival
advantage in situations requiring extended periods of prolonged endurance
exercise because glycogen depletion is associated with physical exhaustion,
and slower utilization of glycogen results in improved endurance exercise
performance. As one of the sources ofblood glucose, liver glycogen plays an
important role in controlling the availability of cellular energy. It is possible
that astaxanthin may have promoted glycogenolysis restraint and/or
gluconeogenesis. In addition, in the astaxanthin groups, the blood lactate
concentration was significantly lower than in the control group (Fig. 2-4a).
Lactic acid is produced as a result of carbohydrate metabolism. These results
indicate that astaxanthin caused a decrease in glucose utilization during
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exerclse.
     Increased fatty acid utilization during exercise reduces the glycogen
depletion rate and improves endurance exercise performance (17). Therefore,
increased fatty acid utilization is thought to be important for endurance
performance. These increases are associated with enhanced lipolysis and
sparing of stored glycogen, resulting in a delay of complete glycogen
depletion by increasing circulating catecholamines. The enhanced availability
of NEFA is thought to cause greater fat metabolism in the active muscles,
which in turn decreases carbohydrate utilization and leads to increased
exercise capacity (18). These concepts agree with the present research results.
In the control group, plasma NEFA concentration was decreased by 15 min of
swimming. However, in the astaxanthin 30 mg/kg group, plasma NEFA was
significantly increased by swimming (Fig. 24c). Astaxanthin activated
utilization of lipid to a greater extent than glucose as an energy source for
performance. There was no significant difference in body weight between'  the
control group and astaxanthin groups for 4 weeks. However, in the 30 mg/kg
astaxanthin group, adipose tissue weight was significantly (P< O.05)
decreased compared to that of the control group (Fig. 2-5). Moreover, the
astaxanthin 6 mg/kg and 30 mg/kg groups, before exercise RER were tended
to be lower than in the control group. Furthermore, the astaxanthin 6 mg/kg
and 30 mg/kg groups, during exercise RER values were lower than in the
control group (Fig. 2-8). These results also suggest that the metabolic effects
of astaxanthin on endurance performance appear to be caused by the increase
in fatty acid utilization as an energy source, with sparing of glycogen. The
glycogen thus saved could become an available energy source for the later
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stages of exercise, thus delaying the onset of fatigue.
     Improvement of cardiopulmonary function and increase of oxygen
supply to tissues as a result of an increase of hemoglobin are commonly stated
to be major factors that increase endurance capacity. In the present study, the
hemoglobin concentration after 4 weeks of administration did not differ from
that at the start of the study (data not shown). These results indicate that
astaxanthin did not influence the supply of oxygen to tissues provided by
hemoglobin.
     It is well documented that a bout of aerobic physical exercise markedly
increases 02 uptake and consumption due to the increased skeletal muscle
energy requirement. This increased 02 consumption further augments the
generation of reactive oxygen species (ROSs) when the scavenging capacity
of both nonenzymatic and enzymatic defense mechanisms is overwhelmed.
This is especially the case during an acute bout of exhaustive exercise. ROSs
has been reported to cause modifications in cellular biochemical components
such as protein, lipid, and DNA (19-21). Furthermore, ROSs, like lactate
anion and protons, have been suggested to be implicated in oxidative skeletal
muscle fatigue. It is reported that ROS alter such transport systems as
potassium transport and thus contribute to the onset of fatigue (22).
Polyunsaturated fatty acids are another ROS target, and their peroxidation
may lead to fluidity and permeability alterations of membrane. Moreover,
lactate anion, independently from proton and thus pH modifications, may
decrease muscle force production by inhibiting Ca2" release from the
sarcoplasmic reticulum and/or by changing ionic strength (23). Astaxanthin
has been reported to be more effective than other antioxidants, such as
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vitamin E and 6-carotene, in preventing lipid peroxidation in solutions and in
various biologic membrane systems (4-6). Astaxanthin can attenuate
exercise-induced damage in mouse skeletal muscle and heart, including an
associated neutrophil infiltration that induces further damage (24). In the
present study, the increase in plasma CK activity of the exercise was inhibited
by treatment with astaxanthin (Fig. 2-7). It is possible to say that astaxanthin
does to free radicals, but stabilizes membranes, delays muscle fatigue, and
thereby enhances endurance.
     In conclusion, these data suggest that astaxanthin have beneficial
effects on endurance capacity. The administration of astaxanthin causes an
increase in utilization of fatty acids as an energy source, which spares
glycogen. However, comprehensive chemical and pharmacological research is
required to determine the mechanism by which astaxanthin affects endurance
capaclty.
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Fig. 2-1. Effect of astaxanthin on swimming exercise in mice; Highintensity load
swimming test (Experiment 1).
The mice were given either vehicle (e), or an astaxanthin dose of 1.2 (D), 6 (A), and 30
(O) mg/kg body weight (n =10 per group). The mice were made to perform swimming
exercise with weights attached to their tails corresponding to 109o of their body weight.
Each value represents mean Å} SE. *:p < O.05, **:p < O.Ol, ***:p < O.O05 vs. control.
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Fig. 2-2. Effect of astaxanthin on swimming exercise in mice; Middleintensity load
swimming test (Experiment 2).
The mice were given either vehicle or an astaxanthin dose of 1.2, 6, and 30 mglkg body
weight for 3 weeks (n = 10 per group). The mice swam with weights attached to their tails
corresponding to 59o oftheir body weight.
Each value represents mean Å} SE. Significant difference from corresponding control group
(*: p<O.05, ***: p<O.O05).
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Fig. 2-3. Effect of astaxanthin supplementation on exerciseinduced fatigue in mice
(Experiment 3).
The mice were given either vehicle or an astaxanthin dose of 1.2, 6, and 30 mglkg body
weight for 5 weeks (n = 10 per group). Exercise induced fatigue of the mice were
performed using a treadmi11. With the aim of accustom to treadmi11, the mice were
performed treadmi11 with a constant speed (20 mlmin) for 15 min at 11:OO to 17:OO
everyday from 4 weeks after. After 5 weeks, the mice were performed using treadmi11 with
a constant speed (25 mlmin) for 1 hour. And then, each of the mice had a weight attached
(59o body weight) to the tail for the duration of the swimtoÅíxhaustion exercise.
Each value represents mean Å} SE. Significant difference from corresponding control group
(*:p < O.05, **:p < O.Ol).
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Fig. 2-4. Effect of astaxanthin on blood lactate, glucose, and NEFA concentration
during swimming for 15 min (Experiment 4)
The mice were given either vehicle (e) or astaxanthin 1.2 mglkg (D), 6 mglkg (A), and
30 mglkg (O) (n = 10 per group). The mice were made to perform swimming exercise
with weights attached to their tails corresponding to 59o of their body weight. Each value
represents mean Å} SE. *:p < O.05, ***:p < O.O05 vs. control.
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Fig. 2-5. Effect of astaxanthin on weight of epididymal adipose
(Experiment 4).
Each value represents mean Å} SE. *: p < O.05 vs. control.
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Fig. 2-6. Effect of astaxanthin on liver and muscle glycogen after 15 min of swimming
    .exerclse.
The mice were given either vehicle or astaxanthin 1.2 mglkg, 6 mglkg, and 30 mglkg for 5
weeks. -: no-exercise, D: exercise. The mice were made to perform swimming exercise
with weights attached to their tails corresponding to 59o of their body weight. Each value
represents mean Å} SE. **:p < O.Ol, ***:p < O.O05 vs. no-exercise. #:p < O.05 vs. exercise
control.
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Fig. 2-7. Effect of astaxanthin on CK activity in plasma after 15 min of swimming
exercise.
The mice were given either vehicle or astaxanthin 1.2 mglkg, 6 mglkg, and 30 mglkg for 5
weeks. -: no-exercise, O: exercise. The mice were made to perform swimming exercise
with weights attached to their tails corresponding to 59o of their body weight. Each value
represents mean Å} SE. *:p < O.05 vs. no-exercise.
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Fig. 2-8. Effects of astaxanthin on the respiratory exchange ratio in mice (Experiment
s
Mice were divided into four groups (n =10N 12). The mice were given either vehicle (e) or
astaxanthin 1.2 mglkg (O), 6 mglkg (/N), and 30 mglkg (O) body weight by stomach
intubation at every day for 6 weeks.
A 10-ane motorized rodent treadmill (Muromachi Kikai, Tokyo, Japan) was used to
exercise. The mice ware run on a treadmill at an inclination of OO and underwent a 3 times
a week for 6 weeks ruming program to enable them run 20 m!min for 40 min as follows:
lst week: 10 min; 2nd week: 20 min; 3rd week: 30 min; 4th week: 40 min; 5th week 40
min. The following week, the mice were deprived of food ovemight. And then, they were
placed in a treadmi11 chamber and allowed to rest for 30 min. They were then made to run
at speed of 20 mlmin for 40 min, during which the respiratory gas was monitored.
Each value represents mean Å} SE. *:p < O.05 vs. control.
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Fig. 2-9. Effects of antioxidants on swimming exercise in mice (Experiment 6)
Fifty mice were divided into five groups (n = 10 per group).The mice were given either
vehicle, astaxanthin in doses of 30 mglkg, SÅíarotene 30 mg/kg, vitamin E 100 mg/kg'and
vitamin C 100 mg/kg body weight by stomach intubation 5 days a week for 6 weeks. Each
of the mice had a Weight attached (79o body weight) to the tail for the duration of the
swimto-exhaustion exercise. The mice were assessed to be fatigued when they failed to
rise to the surface of the water to breathe within 5 seconds.
Each value represents mean Å} SE. *:p < O.05, **:p < O.Ol vs. control.
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          CHAPTER3
Effects of astaxanthin in obese mice fed a
          highfat diet.
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CHAPTER 3. Effects of astaxanthin in obese mice fed a high-fat diet.
3-1. Introduction.
     Obesity is a chronic, stigmatized, and costly disease that is rarely
curable and is increasing in prevalence throughout most of the world. It is an
abnormal condition in which lipid accumulates in adipose tissue. Recently, it
has become well known that obesity is caused by various environmental and
genetic factors (25). One of the main environmental factors causing obesity is
consumption of a high-fat diet, which is common today (26, 27). Obesity is a
risk factor for various diseases, including diabetes, hyperlipidemia, and
hypertension. Therefore, it is very important to prevent obesity for a healthy
life.
     Astaxanthin, a red carotenoid pigment, is a biological antioxidant that
occurs naturally in a wide variety of living organisms. It has many highly
potent pharmacological effects, including antioxidant, antitumor ' and
antiÅíancer, anti-diabetic, and anti-inflammation activities.
     The chronic effects of astaxanthin as an anti-obesity agent, however,
have not been demonstrated. In the present study, we investigated the effect of
astaxanthin in mice fed a high-fat diet.
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3-2. Materials and Methods.
3--2-1. Materials.
     The astaxanthin used in this study was Asta REAL 50 E supplied by
Fuji Chemical Industry Toyama, Japan. In vitro assays, the astaxanthin used
Sigma, St Louis, MO, USA.
3-2-2. Animals.
     Female ddY mice (SLC, Shizuoka, Japan) were used. They were
housed in standard cages (21.5 Å~ 32 Å~ 14 cm, five mice/cage) under
controlled conditions of temperature (24 Å} 10C), humidity (50 Å} 29e), and
lighting (lights on from 08:OO to 20:OO).
3-2-3. Effects of astaxanthin in obese mice fed a highfat diet for 60 days
(Experiment 1).
     Female ddY mice (4 weeks old) were used. After receiving a standard
laboratory diet (Oriental Yeast, Tokyo, Japan) and water ad libitum for 1 week,
they were divided into five groups matched for body weight. One group, the
normal diet group, the basic composition (Table 1.) of the experimental diet
was as follows (w/w per 100 g diet) : beef tallow 49o, casein 149o, alphatorn
starch 15.59o, betaÅíorn starch 46.5692%, sugar 109o, cellulose 59o, vitamin
mixture (AIN-93G) 19o, mineral mixture (AIN-93G) 3.59o, L-cystine O.189o,
choline hydrogen tartrate O.259o, and t-butylhydroquinone O.OO089o. The
other four groups were fed a high-fat diet or a high-fat diet plus astaxanthin.
High-fat diets shared the following basic composition: beef tallow 409o,
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casein 149o, alphaÅíorn starch 15.59o, betaÅíorn starch 10.56929o, sugar 109o,
cellulose 59o, vitamin mixture (AIN-93G) 19o, mineral mixture (AIN-93G)
3.5%, L-cystine O.189o, choline hydrogen tartrate O.259o, and
t-butylhydroquinone O.OO089o (w/w per 100 g diet). The mice were given
either the vehicle (olive oil) or astaxanthin in doses of 1.2, 6, and 30 mg/kg
body weight by stomach intubation for 60 days. Samples were administrated
in a volume of 200 pl. The mice were housed in standard cages (five mice
per cage). The total amount of food intake by each group was recorded every
3 days. The intake of food showed the total intake of each group for 60 days.
The body weight of each mouse was recorded every 3 days. After 60 days, the
mice were killed by anesthesia. Blood samples were collected from the heart.
The concentrations of triglyceride and total cholesterol in the plasma were
determined by enzymatic colorimetric tests with commercial kits (triglyceride
Etest, cholesterol Etest) from Wako Pure Chemical Industries, Tokyo, Japan.
     Parametrial adipose tissue and organs (liver, kidney, spleen, and heart)
were quickly removed and weighed. The liver was stored at -200C until
analysis. The liver triglycerides were extracted by the procedure of Folch et al.
(28) and were determined with a commercial kit.
3-2-4. Effects of astaxanthin in obese mice fed a highfat diet for 90 days
(Experiment 2).
          The protocol was same as above expect that the mice were
divided into five groups matched for body weight (n = 8). One group, the
normal diet group, the other four groups were fed a high-fat diet or a high-fat
diet plus astaxanthin in doses ofO.1, 1, and 10 mg/kg body weight by stomach
                                41
intubation for 90 days. After 60 days, the mice were ki11ed by anesthesia.
Blood samples were collected from the heart. The concentrations of
triglyceride, total cholesterol, GOT and GPT, in the plasma were determined
by enzymatic colorimetric tests with commercial kits (triglyceride Etest,
cholesterol Etest, transaminase CIItest) from Wako Pure Chemical
Industries, Tokyo, Japan. Plasma adiponectin was determined by ELISA
(Otsuka Pharmaceutical, CO., LTD.).
     Parametrial adipose tissue and organs (liver, kidney, spleen, and heart)
were quickly removed and weighed. The liver was stored at -200C until
analysis. The liver triglycerides were extracted by the procedure of Folch et al.
(28) and were determined with a commercial kit.
3-2-5. Lipid- Loading test (Experiment 3).
     Female ddY mice were housed for 1 week under the conditions
described above. They were provided a normal diet (MR stock, Nihon nouSan,
Tokyo, Japan) and water ad lihitum. After the mice had been deprived of food
overnight, they were orally administered O.3 ml of olive oil with or without
astaxanthin at a dose of 30 mg/kg (each group, n = 10). Blood samples were
taken from the tail O, 1, 2, 3, 4, 5, 6, 7, and 8 h after administration. The
concentrations of triglyceride in the plasma were determined by enzymatic
colorimetric tests with commercial kits (triglyceride Etest) from Wako Pure
Chemical Industries, Tokyo, Japan.
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3-2-6. Inhibitory action against pancreatic lipase in vitro (Experiment 4).
     Lipase activity was determined by Lipase Kit S from Dainihon seiyaku,
Co. Ltd, Osaka, Japan.
3--2-6. Respiratory exchange ratio (Experiment 5).
     Male ddY mice were housed for 1 week under the conditions described
above. They were provided a normal diet (MR stock, NIHON NOUSAN,
Tokyo, Japan) and water ad libitum. Twenty mice were divided into two
groups (n=10 per group). The mice were given either vehicle (olive oil) or
astaxanthin in doses of 30 mg/kg body weight by stomach intubation at every
day for 4 weeks. Four weeks later the mice were prohibited access to food 12
h before administration of samples to avoid the effect of the components in
the diet or of digestion and absorption on respiratory gas. The rnice were
administered vehicle (olive oil) or astaxanthin in doses of 30 mg/kg body
weight by stomach intubation. Eight h later, the respiratory gases Were
measured for 1 h. The instruments used for measurement of the respiratory
quotient in mice consisted of acrylic metabolic chambers, gas analyzers
(model LE 405 Gas Analyzer Panlab Technology for Bioresearch, Madrid,
Spain), and a switching system (model LE 400 Air Supply and Switching,
Panlab Technology for Bioresearch).
3-2-7. Effects of astaxanthin on the differentiation of 3T3-Ll cells
Culture and differentiation of 3T3-Ll cells.
     The 3T3-Ll preadipocytes were cultured and induced to differentiate as
described previously. Cells were grown in Dulbecco's modified Eagle's
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medium (DMEM) containing 109o fetal bovine serum (FBS), in 5% C02. Tow
days after the cells were confluent, they were induced to differentiate by
changing the medium to DMEM containing 109o FBS, plus O.5 mmoYL
3-isobutyl-1-methyxanthin (MIX; Sigma, St Louis, MO, USA), 5 mg/mL
insulin (Sigma), 1 mmolAL dexamethasone (Sigma), and astaxanthin 20, 10, 5,
2.5, 1.25 ptM. The medium was changed every 4 d for 16 days.
     Cells were stained with oil red O as described previously. Briefly,
3T3-Ll cells were fixed in 109o formalin (pH 7.4) for 30 min, 3T3-Ll cells
were stained with oil red O for 5 min (stock solution: 3 mg/mL dissolved in
isopropanol; working solution: 609o oil red O stock stain combined with 409e
distilled water).
3-2-7. Statistical analysis.
     All values are expressed as mean Å} SE. Data were analyzed by ANOVA,
and differences among the means of groups were analyzed by the TUkey
multiple comparison test. Differences were considered significant at p < O.05.
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3-3. Resuks.
3-3-1. Effects of astaxanthin in obese mice fed a hightat diet for 60 days
(Experiment 1).
3-3-1-1. Body weight of mice administered vehicle or astaxanthin
(Experiment 1).
     Fig. 3-1. shows the changes in body weight of the groups during the
experiments. Feeding a high-fat diet containing 409o beef tallow caused a
marked increase in body weight as compared to feeding a normal diet.
However, feeding a high-fat diet plus astaxanthin at levels of 6 mg/kg or 30
mg/kg significantly reduced the body weight gain induced by the high-fat diet.
Food intake during the experiments was weighed. Feeding a high-fat diet
caused a marked decrease in food intake as compared to feeding a normal diet,
but astaxanthin did not affect food intake (Fig. 3-2).
3-3-1-2. Periepididymal tissue and liver weight (Experiment 1).
     The mice fed a high-fat diet containing 409o beef tallow for 60 d had a
significantly higher adipose tissue weight than the mice fed the normal diet.
In the high-fat diet plus astaxanthin 30 mg/kg group, adipose tissue weight
was significantly lower than in the mice fed the high-fat diet alone (Fig. 3-3).
In the high-fat diet plus astaxanthin 1.2 mg/kg and 6 mg/kg groups, the
adipose tissue weight tended to be lower than in the group receiving the
high-fat diet alone, but not significantly.
     The high-fat diet plus astaxanthin also significantly suppressed the
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increase in liver weight induced by the high-fat diet alone. The weights of the
kidney, spleen, and heart did not differ significantly among groups (data not
shown).
3-3-1-3. Liver lipid content (Experiment 1).
     The lipid levels in the liver when astaxanthin was administered are
shown in Fig. 34, 3-5. The liver triglyceride level was higher in the high-fat
diet group than the normal diet group. In the high-fat diet plus astaxanthin 6
and 30 mg/kg groups, liver lipids were lower than in the group fed the
high-fat diet alone.
3-3--1-4. Plasma lipids (Experiment 1).
     The plasma triglyceride level was higher in the high-fat diet alone
group than in the normal diet group. However, values in the high--fat diet plus
astaxanthin 6 and 30 mg/kg groups were lower than in the group receiving'the
high-fat diet alone (Fig. 3-6). In the high-fat diet plus astaxanthin 1.2 mg/kg
group, the triglyceride level tended to be lower than in the group fed the
high--fat diet alone, but not significantly. The plasma total cholesterol level
was higher in the high-fat diet alone group than in the normal diet group.
However, values in the high-fat diet plus astaxanthin 30 mg/kg group were
lower than in the high-fat diet alone group.
3-3-1-5. The state of the mice on the 60 days (Experiment 1).
     The appearance on the 60 days had the bad lie of fur in the high-fat diet
group. However, there were not difference in the normal diet group and in the
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astaxanthin group (Fig. 3-7).
3-3-2. Effects of astaxanthin in obese mice fed a highlat diet for 90 days
(Experiment'2).
3-3-2-1. Body weight of mice administered vehicle or astaxanthin
(Experiment 2).
     Figure 3-8 shows the changes in body weight of the groups during the
experiments. Feeding a high-fat diet containing 409o beef tallow caused a
marked increase in body weight as compared to feeding a normal diet.
However, feeding a high-fat diet plus astaxanthin groups significantly reduced
the body weight gain induced by high-fat diet. Food intake during the
experiments was weighed. Feeding a high-fat diet caused a marked decrease
in food intake as compared to feeding a normal diet, but astaxanthin did not
affect food intake (Fig. 3-9).
3-3-2-1. Periepididymal tissue and liver weight (Experiment 2).
     The mice fed a high-fat diet containing 409o beef tallow for 60 d had a
significantly higher epididymal adipose tissue weight than the mice fed the
normal diet. In the high-fat diet plus astaxanthin groups, epididymal adipose
tissue weight was significantly lower than in the mice fed the high-fat diet
alone (Fig. 3-10).
     The high-fat diet plus astaxanthin 1 and 10 mg/kg groups also
significantly suppressed the increase in liver weight induced by the high-fat
diet alone. The weights of the kidney, spleen, and heart did not differ
                                47
significantly among groups (data not shown).
3-3-2-2. Liver lipid content (Experiment 2).
      The lipid levels in the liver when astaxanthin was administered are
shown in Figure 3-11, 3-12. The liver triglyceride level was higher in the
high-fat diet group than the normal diet group. In the high-fat diet plus
astaxanthin 1 and 10 mg/kg groups, liver lipids were lower than in the group
fed the high-fat diet alone.
3-3-2-3. Plasma GOT and GPT (Experiment 2).
     In the high-fat diet group, adiposis hepatica and liver damage were
observed macroscopically (Fig. 3-11). The plasma GOT and GPT level were
higher in the high-fat diet alone group than in the normal diet group. However,
values in the high-fat diet plus astaxanthin 10 mg/kg group was lower than in
the group receiving the high-fat diet alone (Fig. 3-14). In the high-fat diet plus
astaxanthin O.1 and 1 mg/kg groups, the plasma GOT and GPT level tended to
be lower than in the group fed the high-fat diet alone, but not significantly.
3-3-2-4. Plasma lipids (Experiment 2).
      The plasma triglyceride level in the high-fat diet alone group was
higher than in the normal diet group. However, values in the high-fat diet plus
astaxanthin 10 mg/kg was lower than in the group receiving the high-fat diet
alone (Fig. 3-14). In the high-fat diet plus astaxanthin O.1 and 1 mg/kg group,
the triglyceride level tended to be lower than in the group fed the high-fat diet
alone, but not significantly. The plasma total cholesterol level was higher in
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the high-fat diet alone group than in the normal diet group. However, values
in the high-fat diet plus astaxanthin 10 mg/kg group were lower than in the
high-fat diet alone group.
3-3-2-5. Plasma adiponectin (Experiment 2).
      The plasma adiponectin level was lower in the high-fat diet alone
group than in the normal diet group. However, values in the high-fat diet plus
astaxanthin 10 mg/kg was higher than in the group receiving the high-fat diet
alone (Fig. 3-15).
3-3-2-6. The state of the mice on the 90 days (Experiment 2).
     The appearance on the 90 days had the bad lie of fur in the high-fat diet
group. However, there were not difference in the normal diet group and in the
astaxanthin group (Fig. 3-16).
3-3--3. Effects of astaxanthin on plasma triglyceride concentration in a
lipid-oading test (Experiment 3).
     In the lipid-oading test, plasma triglyceride concentration gradually
increased until 4 hour after sample (olive oil or olive oil plus astaxanthin)
administration, and then it gradually decreased. The plasma triglyceride level
was not reduced in the astaxanthin group more than in the vehicle group (Fig.
3-17).
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3-3-4. Effects of astaxanthin on pancreatic lipase activity in vitro
(Experiment 4).
     We tested astaxanthin for inhibitory action against pancreatic lipase in
vitro and found that astaxanthin did not inhibit pancreatic lipase activity (Fig.
3-1 8)
3-3-5. Effects of longterm astaxanthin treatment on respiratory
exchange ratio (Experiment 5).
     Figure 19 shows the changes in metabolic rate in mice administrated
vehicle and astaxanthin 30 mg/kg every day after 4 weeks. The vehicle group
maintained its respiratory quotient at O.90 -O.95. The respiratory quotient was
lower in the astaxanthin 30 mg/kg group than in the mice of the vehicle group
(Fig. 3-19).
3-3-7. Effects of astaxanthin on the differentiation of 3T3-Ll cells.
     Figure 3-20 shows the result of Oil Red O staining and MTT assay.
Preadipocyte viability was not affected by 1.25"20 ptM concentration of
astaxanthin. Oil Red O staining showed that incubation of 1.25N10 ptM
concentration of astaxanthin during the differentiation period not inhibited
3T3-Ll adipogenesis. Astaxanthin 20 yM tended to inhibit 3T3-Ll
adipogenesis ip = O.05).
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3-4. Discussion.
     It is generally accepted that diets high in fat contribute to obesity in
both humans (29) and animal models (30).High fat diet intake is widely
accepted to be associated with a higher risk for obesity and chronic diseases
such as cardiovascular disease, some types of cancer (31), diabetes,
hyperlipidemia, and hypertension. For example, high fat consumption is
related to the prevalence of metabolic syndrome in affluent societies (32).
     In the present study increases in the body weight and weight of adipose
tissue were prevented in mice fed a high-fat diet plus astaxanthin without
changing the energy intake, except in the normal diet group. At the end point
of the experiments, astaxanthin inhibition of elevation in the weights of the
body and of adipose tissue appeared to be dose-dependent (Figs. 3-1, 3-3, 3-8
and 3-10). In addition, astaxanthin reduced liver weight (Fig. 3-3 and 3-10),
liver triglyceride (Fig. 3-5 and 3-12), plasma triglyceride, and total cholesterol
(Fig. 3-6 and 3-14). These results indicate that astaxanthin prevents'the
obesity and fatty liver induced by feeding a high-fat diet.
     Reducing energy intake and increasing energy expenditure are
fundamental to the treatment of obesity. In terms of energy intake, for the
purpose of clarifying the mechanism of the body weight reduction observed in
this study, the effect of astaxanthin on the absorption of triglyceride in the
intestines was investigated. Astaxanthin did not decrease the plasma
triglyceride gain caused by olive oil administration (Fig. 3-17). It is well
known that dietary fat is not absorbed from the intestine unless it has been
subjected to the action of pancreatic lipase. In strategies to prevent obesity,
one of the key steps is inhibition of the digestion and absorption of dietary fat.
                                51
We tested astaxanthin for inhibitory action against pancreatic lipase in vitro
and found that astaxanthin did not inhibit pancreatic lipase activity (Fig. 3-18).
Thus, our findings indicate that astaxanthin does not affect energy intake.
     Astaxanthin might affect energy expenditure, however. Because
thermogenesis and fat oxidation are to a large extent under the control of the
sympathetic nervous system, approaches that mimic or interfere with the
sympathetic nervous system and its neurotransmitter norepinephrine offer a
rational approach to obesity management (33, 34). For example, capsaicin has
been reported to increase catecholamine secretion and energy expenditure and
to suppress body fat accumulation during longterm treatment in experimental
animal studies (35-37). Oral administration of capsaicin resulted in increased
endurance time during prolonged work. These increases were associated with
enhanced lipolysis and sparing of glycogen, which results in delaying
complete glycogen depletion through an increase in circulating catecholamine.
In our previous study, astaxanthin may have had beneficial effects' on
endurance capacity (38). Astaxanthin increased the supply of blood free fatty
acid in the early phase of exercise. The administration of astaxanthin causes a
decrease in the utilization of glucose and an increase in the utilization of fatty
acid as an energy source during exercise, which spares glycogen. According
to the results of this study, astaxanthin can stimulate an increase in fatty acid
utilization.
     In the study we analyzed the respiratory gas of mice administrated
vehicle and astaxanthin 30 mg/kg at every day for 4 weeks. Analysis was
started at the last administration and for 8 hour afterward, because generally
the astaxanthin concentration in the blood can be detected at 2 hour reaches a
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peak at 6-7 hours, and exists in the blood till 72 hours (1). The half-life is 21
hours. This study indicates that after longterm administration of astaxanthin,
the respiratory quotient was lower in the astaxanthin 30 mg/kg group than in
the mice of vehicle group (Fig. 3-19). Astaxanthin might stimulate an increase
in fatty acid utilization in daily life. I must measure uncoupling protein in
brown adipose tissue or beta-oxidase enzymes in liver and muscle. Further
studies are necessary to elucidate the mechanisms.
     High-fat diet induced insulin resistance associated with obesity is major
risk factor for diabetes and cardiovascular disease, the prevalence of which is
increasing sharply (87). However, the molecular basis for this association
remains to be elucidated. The adipose tissue itself serves as the site of
triglyceride storage and free fatty acid/glycerol release in response to
changing energy demands (87). Adipose tissue also participates in the
regulation of energy homeostasis as an important endocrine organ that
secretes a number of biologically active adipokines. Adiponectin is one such
adipokine that has recently attracted much attention. In the study, the plasma
adiponectin level was lower in the high-fat diet alone group than in the
normal diet group. However, values in the high-fat diet plus astaxanthin 10
mg/kg was higher than in the group receiving the high-fat diet alone (Fig.
3-15). Astaxanthin might regulate of adipokines.
     In this study, I examined astaxanthin effectiveness in inhibiting 3T3-Ll
adipocyte differentiation. However, Incubation of 1.25A'10 yM
concentration of astaxanthin during the differentiation period not inhibited
3T3-Ll adipogenesis. Astaxanthin 20 pM tended to inhibit 3T3-Ll
adipogenesis (p = O.05). This anti-differentiation activity by astaxanthin was
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very weak.
     In conclusion, we found that astaxanthin inhibits the elevations in body
weight and adipose tissue weight caused by a high-fat diet. In addition,
astaxanthin reduced liver weight, liver triglyceride, plasma triglyceride, and
total cholesterol. These results indicate that astaxanthin might be of value in
preventing obesity and the metabolic syndrome in affluent societies.
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Table 1. Composition of diets ( 9o )
Normal-diet Highifat diet
Casein
Beef tallow
Alpha-corn starch
Beta-corn starch
Sugar
Cellulose
Vitamin mixture
Mineral mixtur
L-systine
Choline hydrogen tarate
tbutylhydroquinone
14
4
15.5
46.5692
10
5
1
 35
 O.18
 O.25
 O.OO08
14
40
155
10.5692
10
5
1
 35
 O.18
 O.25
 O.OO08
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Fig. 3-1. Body weight of mice administered vehicle or astaxanthin at 1.2, 6, and 30
mgtkg. during the experimental period (Experiment 1).
M: normal diet, -: high-fat diet, ZN: high-fat diet + astaxanthin 1.2 mglkg, O: high-fat
diet + astaxanthin 6 mglkg, Å~ : high-fat diet + astaxanthin 30 mglkg. Values are means Å}
SE (n = 8 per group)
#:p < O.05, ##:p < O.Ol vs. normal diet.
":p < O.05, "",p < O.Ol, 6mglkg vs. high-fat diet.
$: p < O.05, $$:p < O.Ol, 30mglkg vs. high-fat diet.
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Fig. 3-2. Total food intake over 60 days (Experiment 1).
The mice were housed in standard cages (five mice per cage). The total amount of food
intake by each group was recorded every 3 days. The intake of food shown is the total
intake for 60 days for each group.
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Fig. 3-3. Effects of astaxanthin on parametrial adipose tissue and liver weight in mice
fed a hightat diet for 60 days (Experiment 1).
Values are means Å} SE (n = 8 per group)
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                       Astaxanthin
The condition of the liver on the 60 days (Experiment 1).
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Fig. 3-5. Effects of astaxanthin on liver triglyceride in mice fed a high-fat diet for 60
day (Experiment 1).
Values are means Å} SE (n = 8 per group). **:p < O.Ol vs. high-fat diet.
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Fig. 3-6. Effects of astaxanthin on plasma triglyceride and cholesterol in mice fed a
highlat diet for 60 days (Experiment 1).
Values are means Å} SE (n = 8 per group)
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Fig. 3-7. The state of the mice on the 60 days (Experiment 1).
The appearance on the 60 days had the bad lie of fur in the high-fat-diet group.
there were not difference in the normal diet group and in the astaxanthin group.
However,
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Fig. 3-9. Total food intake over 90 days (Experiment 2).
The mice were housed in standard cages (five mice per cage). The total amount of food
intake by each group was recorded every 3 days. The intake of food shown is the total
intake for 90 days for each group.
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Fig. 3-12. Effects of astaxanthin on liver triglyceride in mice fed a high-fat diet for 90
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Values are means Å} SE (n =8 per group)
":p < O.05, *"*:p < O.O05 vs. high-fat diet.
67
240
=g 2oo
g
eM 16o
g 12o
s--
ts 80
es
s
k 4o
ac
o
l
l
Normal Mghlat O.1 1 10
Hightat + Astaxantlm (nrgtkg)
Ae 2ooN
-vE
16og
  120#o
pt. 80
g
X 40
gÅío
l
1
***
*
Nomial Hightat O.1 1 10
Hightat + Astaxanthin (mg/kg)
Fig. 3-14. Effects of astaxanthin on plasma triglyceride and cholesterol in mice fed a
hightat diet for 90 days <]i xperiment 2).
Normal: Normal diet, High-fat: High-fat diet.
Values are means Å} SE (n =8 per group)
*:p < O.05, **:p < O.Ol,p < O.O05 vs. high-fat diet.
68
2.5
{t 2.0
.V"
H
V 1.5
o:
og i.o
es
esg o.s
es
pttu
o.o
r
*
*
Normal Htghtat O;1 1 10
Hightat + Astaxanthin (Mg/kg)
Fig. 3-15. Effects of astaxanthin on plasma adiponectin in mice fed a high-fat diet for
90 days <Experiment 2).
Normal: Normal diet, High-fat: Highifat diet.
Values are means Å} SE (n =8pe.r group)
": p < O.05 vs. high-fat diet.
69
'i
b
'?st" idi'tt'//;-' '
Highifat diet High-fat diet +Astaxanthin lO mglkg
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Fig. 3-17. Effect of astaxanthin on plasma triglyceride concentration in a lipid-oading
test (Experiment 3)
M, vehicle; e, astaxanthin 30 mglkg.
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Fig. 3-19. Effect of longterm astaxanthin treatment on respiratory exchange ratio
(Experiment S.
e, vehicle; [], astaxanthin 30 mglkg. Each value represents mean Å} SE.
*,p < O.05; *",p < O.Ol vs. vehicle.
Twenty mice were divided into two groups (n = 10 per group). The mice were given either
vehicle (olive oil) or astaxanthin in doses of 30 mglkg body weight by stomach intubation
every day for 4 weeks. Four weeks later the mice were prohibited access to food 12 hour
before administration of samples to avoid the effect of components in the diet and of
digestion and absorption on respiratory gas. Mice were rested in a metabolic chamber for
60 min.
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             CHAPTER 4
Effects of astaxanthin and exercise; Promoting
 energy metabolism and suppressing body fat
          accumulation in mice.
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CHAPTER 4. Effects of astaxanthin and exercise; promoting energy
metabolism and suppressing body fat accumulation in mice.
4-1. Introduction.
     Obesity is a chronic, stigmatized, and costly disease that is rarely
curable and is increasing in prevalence throughout most of the world. Obesity
is an abnormal condition in which lipid accumulates in adipose tissue.
Recently, it has become well known that obesity is caused by various
environmental and genetic factors (39). One of the main environmental
factors causing obesity is consumption of a high-fat diet, which is widespread
today (40, 41). Obesity can be a risk factor for diseases including diabetes,
hyperlipidemia, and hypertension. Therefore, it is very important to prevent
obesity for a healthy life.
     Exercise training and regular physical activity are known to increase fat
oxidation in both healthy and obese individuals. It is likely that several
benefits of regular exercise, such as decreased insulin resistance, lower blood
pressure and reduced levels of plasma LDL, are related to enhanced oxidation
of fat (42). Since low-intensity prolonged exercise training is well known to
increase skeletal muscle mitochondrial enzymes involved in both
tricarboxylic acid cycle (TCA) activity and fatty acid 6-oxidation (43, 46).
     We have previously reported that astaxanthin may have had beneficial
effects on endurance capacity. Astaxanthin increased the supply of blood free
fatty acid in the early phase of exercise. The administration of astaxanthin
causes a decrease in utilization of glucose and an increase in utilization of
fatty acid as an energy source during exercise, which spares glycogen. In
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addition in our previous study, the effects of astaxanthin supplementation in
obese mice fed a high-fat diet. Astaxanthin inhibited the increases in body
weight and the weight of adipose tissue that result from feeding a high-fat
diet.
     We investigated the effects of an oral administration of astaxanthin and
exercise in obese mice fed a high-fat diet and fatty acid oxidation enzyme
activity in mice skeletal muscle.
77
4-2. Materials and Methods.
4--2-1. Materials.
     The astaxanthin used in this study was AstaREAL 50 F, supplied by
Fuji Chemical Industry Co., Ltd, Toyama, Japan. In vitro assays, the
astaxanthin used Sigma, St Louis, MO, USA.
4-2-2. Animals.
     Male and female ddY mice (SLC, Japan) were used. They were housed
in standard cages (21.5Å~32Å~14 cm, 5 mice/cage) under controlled conditions
of temperature (24Å}10C), humidity (50Å}29o), and lighting (lights on from
08:OO to 20:OO).
     Animal studies were performed according to the regulations of our
laboratory in line with the 1980 guideline Notification No. 6 of the Prime
Minister 's Office of Japan. '
4-2-3. Effects of astaxanthin and exercise; promoting energy metabolism
and suppressing body fat accumulation in mice (Experiment 1).
     Fifty female Std: ddY mice (4 weeks old) were used. After receiving a
normal diet and water ad libitum for 1 week, they were divided into two
groups matched for body weight. They were divided the sedentary and
exercise group. These groups were further sub-grouped according to the
normal diet group, high-fat diet group and high-fat diet plus astaxanthin (1.2,
6, and 30 mg/kg) groups. Normal diet group, the basic composition of the
experimental diet was as follows (w/w per 100 g diet) : beef tallow 4%, casein
                    '
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149o, alphaÅíorn starch 15.59o, betatorn starch 46.56929o, sugar 10%,
cellulose 59o, vitamin mixture (AIN-93G) 19o, mineral mixture (AIN-93G)
3.5 9o , L-cystine O. 18 9o , choline hydrogen tartrate O.25 9o , t-butylhydroquinone
O.OO089o. The other groups were fed a high-fat diet or a high-fat diet plus
astaxanthin. High-fat diets shared the following basic composition: beef
tallow 409o, casein 149o, alphaÅíorn starch 15.59o, betaÅíorn starch 10.56929o,
sugar 109o, cellulose 59o, vitamin mixture (AIN-93G) 19o, mineral mixture
(AIN-93G) 3.59o, L-cystine O.189o, choline hydrogen tartrate O.259o,
t-butylhydroquinone O.OO089o (w/w per 100 g diet). The mice were given
either the vehicle (olive oil) or astaxanthin in doses of 1.2, 6, and 30 mg/kg
body weight by stomach intubation for 60 days. Samples were administrated
in a volume of 200 pL. The mice were housed in standard cages (5 mice per
cage). Each groups total amount of food intake by each groups was recorded
every three days. The intake of food showed the total intake of every group
for 60 days. The body weight of each mouse was recorded every three days.
After sixty days, the mice were ki11ed by anesthesia. Blood samples were
collected from the heart. The concentrations of triglyceride, total cholesterol,
glucose, GOT and GPT in the plasma were determined by enzymatic
colorimetric tests with commercial kits (triglyceride Etest, cholesterol Etest,
glucose CII{est, transaminase CIItest) from Wako Pure Chemical Industries,
Japan. Parametrial adipose tissue and organs (liver, kidney and spleen) were
quickiy removed and weighed. Liver was stored at - 800C until analysis. The
liver triglycerides were extracted by the procedure of Folch et al. (28) and
were determined by a commercial kit.
     Exercise training of the mice were performed using a treadmi11 (Model
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MK-680 Muromachi Kikai Co. Ltd., Japan) with a constant speed (20 m/min)
at 11:OO to 17:OO every day for 60 days. Running time was increased
gradually from 15 min by 5min daily for 5 day. From 5th day running time
was fixed to 40 min.
4-2-4. Effects of astaxanthin and exercise on mitochondrial enzymes in
mice fed a hightat diet for 60 days (Experiment 2).
     Sixty male Std: ddY mice (4 weeks old) were used. After receiving a
normal diet and water ad libitum for 1 week, they were divided into two
groups matched for body weight. They were divided the sedentary and
exercise group. These groups were further sub- grouped according to the
normal diet group, high-fat diet group and high-fat diet plus astaxanthin 6
mg/kg (n=10). The mice were given either the vehicle (olive oil) or
astaxanthin in doses of 6 mg/kg body weight by stomach intubation for 60
days. Samples were administrated in a volume of 200 pL. Exercise training of
the mice were performed using a treadmi11 with a constant speed (20 m/min)
at 11:OO to 17:OO three times for week. Running time was increased gradually
from 15 min by 5min daily for 5 day. From 5th day running time was fixed to
40 min. After sixty days, the mice were killed by dislocation of the neck.
Blood samples were collected from the heart. Blood samples were determined
for lactate, glucose, NEFA, Tq TC, 3-hydroxybutyric acid and creatine
kinase (CK). Liver and muscle samples were clamp-frozen in liquid nitrogen
and stored at -800C until analysis.
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Muscle enzyme activities.
     For enzyme activity measurements 59o homogenates were made from
the respective muscles in 175 mM KCI, 10 mM of glutathione (GSH), and 2
mM of ethylenediamine tetraacetic acid (EDTA), pH 7.4. This homogenate
was frozen and thawed three times and mixed thoroughly before enzymatic
measurements.
     Citrate synthase [EC4.1.3.7] Muscle Citrate synthase (CS) activity
was assayed by the method of Srere (47) with a slight modification. The
homogenate was diluted (1:50) (voVvol) with 10 mM
tris(hydroxymethyl)aminomethane (Tris) buffer. The reaction mixture
contained 100 mM Tris (pH 8.0), 3 mM acetyl-CoA, 1 mM
5.5'-dithiobis[2-nitrobenzoic acid] (DTNB), plus homogenate. After
temperature equilibration at 300C, the change in optical density was recorded
in 30 sec intervals after starting the reaction with 5 miVI oxaloacetate.
     Succinate dehydrogenase [ECI.3.99.1] Succinate dehydrogenase
(SDH) activity was assayed by methods of Ackrell et al. (48) with a slight
modification. Briefiy, O.2 mi of 20 mM Tris-HCI buffer (pH 7.35) was mixed
with O.25 ml of 10 mM potassium ferricyanide, and incubated at 370C for 10
min. The reaction was started by adding O.25 mi of sample solution and the
optical density at 420 nm was measured for 5 min.
     3-Hydroxyacyl CoA dehydrogenase [ECI.1.1.35] 3-Hydroxyacyi
CoA dehydrogenase (3-HAD) activity was assayed according to the method
of Bass (49). In a cuvette, O.8 mi reaction mixture (167 mM triethanolamine,
50 mM EDTA, 4.5 mM NADH,) was combined with O.1mi of homogenate.
The reaction was started by the addition of O.1 mi acetoacetyl-CoA and
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allowed to proceed for 3 min at 300C. The disappearance of NADH was
monitored spectrophotometrically at 340 nm.
 4-2-5. Effects of astaxanthin and exercise on mitochondrial enzymes in
mice skeletal muscle (Experiment 3).
     Forty male Std: ddY mice (5 weeks old) were used. After receiving a
normal diet (MR stock, NIHON NOUSAN, Japan) and water ad lihitum for 1
week, they were divided into two groups matched for body weight. They were
divided the sedentary and exercise group. These groups were further sub-
grouped according to the control group and astaxanthin 6 mg/kg (n = 10). The
mice were given either the vehicle (olive oil) or astaxanthin in doses of 6
mg/kg body weight by stomach intubation for 6 weeks. Samples were
administrated in a volume of 200 pL. Exercise training of the mice were
performed using a treadmill with a constant speed (20 mlmin) at 11:OO to
17:OO three times for week. Running time was increased gradually frorri 15
min by 5min daily for 5 day. From 5th day running time was fixed to 40 min.
After sixty days, the mice were killed by dislocation of the neck. Muscle
samples were clamp-frozen in liquid nitrogen and stored at -800C until
analysis. Assays were performed by the following methods: citrate synthase
(47), succinate dehydrogenase (48), malate dehydrogenase (50) and
3-hydroxyacyl CoA dehydrogenase (49)
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4-2-6. Statistical analysis.
      All values are expressed as mean Å} SE. Data were analyzed by
ANOVA, and differences among mean of groups were analyzed using Tukey
multiple comparison test. Differences were considered significant atp < O.05.
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4-3. Results.
4-3-1. Effects of astaxanthin and exercise; promoting energy metabolism
and suppressing body fat accumulation in mice (Experiment 1).
4-3-1-1. Change of Body Weight (Experiment 1).
     Food intake during the experiments was weighed. Feeding a high-fat
diet caused a marked decrease in food intake as compared to feeding a normal
diet, but astaxanthin did not affect food intake.
     Body weight changes are shown Fig. 4--1. Sedentary group, feeding a
high-fat diet containing 409o beef tallow caused a marked increase in body
weight as compared to feeding a normal diet. Sedentary group in the high-fat
diet plus astaxanthin 1.2 mg/kg was no significant than sedentary group in the
high-fat diet alone. However, feeding a high-fat diet plus astaxanthin at levels
of 6 and 30 mg/kg significantly reduced the body weight gain induced by.the
high-fat diet (Fig. 4-la).
     In common, exercise group in the high-fat diet was significantly higher
than the exercise group in the normal diet. Exercise group in the high-fat diet
plus astaxanthin 1.2 mg/kg was significantly than the exercise group in the
high-fat diet alone (Fig. 4-lb).
4--3--2. Periepididymal tissue and Liver weight (Experiment 1). '
     Both sedentary groups and exercise groups, the mice fed a high--fat diet
containing 409o beef tallow for 60 days had a significantly higher adipose
tissue weight than the mice fed the normal diet.
     Sedentary group, in the high-fat diet plus astaxanthin 6 and 30 mg/kg,
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adipose tissue weight were significantly lower than the sedentary group in the
fed the high-fat diet alone (Fig. 4-2). But the sedentary group, in the high-fat
diet plus astaxanthin 1.2 mg/kg, the adipose tissue weight tended to be lower
than in the group receiving the high-fat diet alone, but not significantly.
     Exercise group, in the high-fat diet plus astaxanthin 1.2 mg/kg, adipose
tissue weight was significantly lower than the exercise group in the high-fat
diet alone.
     Sedentary group, the high-fat diet plus astaxanthin 6 and 30 mg/kg, also
significantly suppressed the increase in liver weight induced by the sedentary
group in the high-fat diet alone (Fig. 4-3). Exercise group, in the high-fat diet
plus astaxanthin were significantly suppressed the increase in Iiver weight
induced by the one's in the high-fat diet alone. Weights of the kidney, spleen,
and heart did not differ significantly among groups (data not shown).
4-3-1-3. Plasma triglyceride, total cholesterol and glucose (Experiment 1).
     Sedentary group, the plasma triglyceride level was higher the sedentary
group in the high-fat diet alone than the sedentary group in the normal diet.
However, values in the high-fat diet plus astaxanthin 6 and 30 mg/kg groups
were lower than in the group receiving the sedentary group in the high-fat diet
alone (Fig. 4-4). In the high-fat diet plus astaxanthin 1.2 mg/kg group, the
triglyceride level tended to be lower than in the group fed the high-fat diet
alone, but not significantly.
     Exercise group, the plasma triglyceride level tended to be lower than in
the sedentary group fed the high-fat diet.
     Both sedentary groups and exercise groups, the mice fed a high-fat diet
containing 409o beef tallow for 60 days, the plasma total cholesterol level
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tended to be higher than in the normal diet group, but not significantly (Fig.
4-5).
     Plasma glucose level did not affect by high-fat diet for 60 days (Fig.
46).
     The high-fat diet containing 409o beef tallow for 60 days, the plasma
GOT and GPT level tended to be higher than in the normal diet group, but not
significantly (Fig. 4-7).
4-3-1-4. Liver trigliceride Content (Experiment 1).
     The lipid levels in the liver when astaxanthin had been administered are
shown in Fig. 4-8. Both sedentary groups and exercise groups, the liver
triglyceride level was higher in the high-fat diet groups than the normal diet
groups.
     Sedentary group, in the high-fat diet plus astaxanthin 6 and 30 mg/kg,
liver triglyceride were lower than the sedentary group in the high-fat diet
alone.
     Exercise group, in the high-fat diet plus astaxanthin 1.2, 6 and 30
mg/kg, liver triglyceride were lower than the exercise group in the high-fat
diet alone. In addition, exercise groups, liver triglyceride were lower than in
the sedentary group.
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4-3-2. Effects of astaxanthin and exercise on mitochondrial enzymes in
mice fed a highlat diet for 60 days. (Experiment 2).
4-3-2-1. Change of Body Weight (Experiment 2).
     Body weight changes are shown Fig. 4-9. Sedentary groups, feeding a
high-fat diet containing 409o beef tallow caused a marked increase in body
weight as compared to feeding a normal diet. The sedentary group in the
high-fat diet plus astaxanthin at levels of 6 mg/kg significantly reduced the
body weight gain induced by the high-fat diet.
     In common, exercise group in the high-fat diet was significantly higher
than the exercise group in the normal diet. The exercise group in the high-fat
diet plus astaxanthin 6 mg/kg was significantly than the exercise group in the
high-fat diet alone.
     Food intake during the experiments was weighed. Feeding a high-fat
diet caused a marked decrease in food intake as compared to feeding a normal
diet, but astaxanthin did not affect food intake.
4-3-2-2. Epididymal adipose tissue and Liver weight (Experiment 2).
     Both sedentary groups and exercise groups, the mice fed a high-fat diet
containing 40% beef tallow for 60 days had a significantly higher adipose
tissue weight than the mice fed the normal diet (Fig. 4-10).
     Sedentary group, in the high-fat diet plus astaxanthin 6 mg/kg, adipose
tissue weight were significantly lower than in the mice fed the high-fat diet
alone.
     Exercise group, in the high--fat diet plus astaxanthin 6 mg/kg, adipose
tissue weight was significantly lower than the exercise group in the high-fat
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diet alone. In addition, exercise groups, adipose tissue weight were lower than
in the sedentary groups.
     Sedentary group, the high-fat diet plus astaxanthin 6 mg/kg, also
significantly suppressed the increase in liver weight induced by the high-fat
diet alone (Fig. 4-11). Exercise group, the high-fat diet plus astaxanthin were
significantly suppressed the increase in liver weight induced by the high-fat
diet alone. Weights of the kidney, spleen, and heart did not differ significantly
among groups (data not shown).
4-3-2-3. Liver triglyceride Content (Experiment 2).
     The triglyceride levels in the liver when astaxanthin had been
administered are shown in Fig. 4-12. Both sedentary groups and exercise
groups, the liver triglyceride level was higher in the high-fat diet group than
the normal diet group.
     Sedentary group in the high-fat diet plus astaxanthin 6 mg/kg, liver
triglyceride were lower than the sedentary group in the high-fat diet alone.
     Exercise group in the high-fat diet plus astaxanthin 6 mg/kg, liver
triglyceride were lower than the exercise group in the high-fat diet alone. In
addition, exercise groups, liver triglyceride were lower than in the sedentary
groups.
4-3-24. Muscle weight (Experiment 2).
     The amount of gastrocnemius muscle weight and Quadriceps muscle
weight per body weight were increased by exercise (Fig. 4-13). Exercise
group in the high-fat diet plus astaxanthin 6 mg/kg, muscles weight were
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higher than the exercise group in the high-fat diet alone.
4-3--2-S. Plasma triglyceride, total cholesterol, glucose, NEFA,
3-hydroxybutyric acid (Experiment 2).
     Sedentary group, the plasma triglyceride level was higher in the
high-fat diet alone group than the normal diet group. In the high-fat diet plus
astaxanthin 6 mg/kg group was lower than in the group receiving the high-fat
diet alone (Fig. 4-14).
     Exercise group, the plasma triglyceride level was lower than in the
group receiving the high-fat diet alone. In addition, astaxanthin 6 mg/kg
groups, plasma triglyceride level were decreased by exercise.
     Sedentary group, the mice fed a high-fat diet containing 409o beef
tallow for 60 days, the plasma total cholesterol level was higher than in the
normal diet group (Fig. 4-14). But plasma total cholesterol level did not affect
by astaxanthin and exercise.
     Plasma glucose level did not affect by high-fat diet for 60 days (Fig.
4-15).
     The high-fat diet containing 40% beef tallow for 60 days, the plasma
NEFA level was higher than in the normal diet but, did not affect by
administration of astaxanthin (Fig. 4-16). The plasma NEFA level tended to
increased by exercise, but not significantly
     Exercise group, the plasma 3-hydroxybutyric acid level tended to be
higher in the high-fat diet plus astaxanthin than the high-fat diet alone group
(Fig. 4-16).
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4-3-26. Mitochondrial enzymes activities (Experiment 2).
     Citrate synthase activity was elevated by high-fat diet and exercise
(Fig. 4-17). Astaxanthin groups, citrate synthase activity tended to be higher
in the high-fat diet, but not significantly.
     Succinate dehydrogenase activity was elevated by exercise (Fig. 4-18).
Astaxanthin groups, succinate dehydrogenase activity tended to be higher in
the high-fat diet, but not significantly.
     3-hydroxyacil CoA dehydrogenase activity was elevated by high-fat
diet and exercise (Fig. 4-19). Sedentary group, high-fat plus astaxanthin was
higher than the sedentary group in the high--fat diet alone. Exercise group,
high-fat plus astaxanthin was higher than the exercise group in the high-fat
diet alone. 3-hydroxyacil CoA dehydrogenase activity was more increased by
combination of astaxanthin and exercise.
4-3-3. Effects of astaxanthin and exercise on mitochondrial enzymes in
mice skeletal muscle (Experiment 3).
4-3-3-1. Change of Body Weight (Experiment 3).
     Body weight changes are shown Fig. 4-20. Exercise groups, body
weight tended to be lower than sedentary groups, but not significantly.
     Food intake during the experiments was weighed. Astaxanthin did not
affect food intake.
4-3-3-2. Epididymal adipose tissue weight (Experiment 3).
     Exercise groups, epididymal adipose tissue weight were significantly
lower than in the sedentary groups (Fig. 4-21). Exercise and astaxanthin 6
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mg/kg group, adipose tissue weight was significantly lower than in the
sedentary astaxanthin group. Epididymal adipose tissue weight was more
decreased by combination of astaxanthin and exercise. Weights of the kidney,
spleen, and heart did not differ significantly among groups (data not shown).
4-3-3-3. Muscle weight (Experiment 3).
     The amount of gastrocnemius muscle weight and Quadriceps muscle
weight per body weight were increased by exercise (Fig. 4-22). However,
astaxanthin did not affect muscles weight.
4-3-34. Mitochondrial enzymes activities (Experiment 3).
     Citrate synthase activity was elevated by exercise (Fig. 4-23).
Sedentary astaxanthin group was significantly higher than in the sedentary
control group. In addition, exercise astaxanthin group was significantly higher
than in the exercise control group. Citrate synthase activity was More
increased by combination of astaxanthin and exercise.
     Succinate dehydrogenase activity was elevated by exercise (Fig. 4-24).
Sedentary astaxanthin group was significantly higher than in the sedentary
control group. Exercise astaxanthin group was higher than in the exercise
control group, but not significantly. Succinate dehydrogenase activity tended
to be more increased by combination of astaxanthin and exercise.
     Malate dehydrogenage activity was elevated by exercise (Fig. 4-25).
Administrated of astaxanthin groups were tended to be higher than in the
control groups, but not significantly.
     3-hydroxyacil CoA dehydrogenase activity was elevated by exercise
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(Fig. 4--26). Sedentary, astaxanthin group was higher than in the sedentary
control group. Exercise, astaxanthin group was higher than in the exercise
control group. 3-hydroxyacil CoA dehydrogenase activity was more increased
by combination of astaxanthin and exercise.
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4-4. Discussion.
     Understanding exercise physiology is important both for the
maintenance of our health and for sports training programs. Many obesity and
lifestyle related diseases are caused by a lack of exercise and by disturbance
of eating habits. Therefore, regular exercise and improvement in our diet are
highly recommended for disease prevention. In addition, lipid and
carbohydrate metabolism has major effects both on development of obesity
and exercise endurance, suggesting that energy metabolism is key factor in
both cases.
     In this study, we examined the effects of astaxanthin and exercise,
promotes energy metabolism and suppresses body fat accumulation in mice.
Feeding a high-fat diet plus astaxanthin significantly reduced the body weight
gain (Fig. 4-1, 4-9) and adipose tissue weight (Fig. 4-2, 4-10) induced by the
high-fat diet. In addition, astaxanthin reduced liver weight (Fig. 4-3, 4-11),
liver triglyceride (fig. 4-8, 4-12), plasma triglyceride (Fig. 4-4, 4-14). The
                                                   '
effects were heightened by combination of astaxanthin and exercise. These
results indicate that astaxanthin prevents the obesity and fatty liver induced by
feeding a high-fat diet, and more heightened by combination of astaxanthin
and exercise. In this study, astaxanthin may have had beneficial effects on
endurance capacity (Chapter 1) (45).-Astaxanthin increased the supply of
blood free fatty acid in the early phase of exercise. The administration of
astaxanthin causes a decrease in the utilization of glucose and an increase in
the utilization of fatty acid as an energy source during exercise, which spares
glycogen. According to the results of this report, astaxanthin can stimulate an
increase in fatty acid utilization. The present study aimed to clarify the
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manner of this effect.
     The present investigation demonstrated that effects of astaxanthin and
exercise on mitochondrial enzymes in mice fed a high-fat diet for 60 days.
Citrate synthase activity (Fig. 4-17) and 3-hydroxyacil CoA dehydrogenase
activity (Fig. 4-19) were elevated by high-fat diet, succinate dehydrogenase
activity (Fig. 4-18) tended to be higher than normal diet, did not significantly.
These results, the tissue must be experiencing some adaptations to the high-fat
diet. Miller et al. reported that mitochondrial enzymes (skeletal muscle) were
increased by high-fat and low carbohydrate diet (51, 52). Also, the range of
elevation in citrate synthase activity was 16-309o, which coincides with
values reported by Jansson for succinate dehydrogenase and 3-hydroxylacil
CoA dehidrogenage (53). These reports accorded with our results. Citrate
synthase (Fig. 4-17) and succinate dehydrogenase activity (Fig. 4-18),
administration of astaxanthin tended to be higher than high-fat diet groups
(sedentary and Exercise groups), but not significantly. 3-hydroxyacyl CoA
dehydrogenase activity (Fig. 4-19) was elevated by exercise. Sedentary,
astaxanthin group was higher than in the sedentary control group. Exercise,
astaxanthin group was higher than in the exercise control group.
3-hydroxyacil CoA dehydrogenase activity was more increased by
combination of astaxanthin and exercise. However the effects of astaxanthin
                                           '
was not clear, because enzyme activity enhanced by high-fat diet.
     Therefore, our investigation demonstrated that effects of astaxanthin
and exercise on mitochondrial enzymes in mice fed a normal diet for 60 days.
Mitochondrial enzymes activity (Citrate synthase, succinate dehydrogenase,
malate dehydrogenase and 3-hydroxyacil CoA dehydrogenase activity) were
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elevated by exercise (fig. 4-23, 4-24, 4-25, 4-26). Sedentary astaxanthin group
was Citrate synthase, succinate dehydrogenase, and 3-hydroxyacil CoA
dehydrogenase activities were elevated. Malate dehidrogenase activity tended
to be higher than control group, but not significantly (Fig. 4-25). Exercise
astaxanthin group, Citrate synthase, and 3-hydroxyacil CoA dehydrogenase
activities were higher than in the exercise control group. Citrate synthase,
3-hydroxyacil CoA dehydrogenase activity was more increased by
combination of astaxanthin and exercise.
     Repeated exercise, defined as physical exercise training, mitochondrial
enzyme activities in skeletal muscle recruited during exercise (51-53). It has
been generally believed that fatty acid oxidation enzyme activity increases in
response to low- to moderate-intensity prolonged exercise, during which lipid
fuel sources are important energy substrates for skeletal muscle.
3-hydroxylacil CoA dehydrogenase and citrate synthase activity in muscle are
increased by treadmi11 runningtraining and the metabolism in muscles shjfts
to more oxidative state. In our investigation, the same results that the
mitochondrial enzyme activities were accelerated by the running exercise.
Moreover, mitochondrial enzyme activities were more increased by
combination of astaxanthin and exercise. These suggests that the 6-oxidation
metabolic pathway is more activated and the energy souse (acetyl CoA) for
mechanical muscle activity tends towards fatty acid rather than carbohydrate
metabolism by combination of astaxanthin and exercise.
     In conclusion, the present results demonstrated that combination of
astaxanthin and/or exercise was more effective for decreasing body weight,
epididymal adiposetissue weight. Moreover, mitochondrial enzyme activities
                   '
                                                        '
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were more increased by combination of astaxanthin and exercise.
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Fig. 4-1. Body weight of mice administrated astaxanthin and exercise fed a hightat
diet (Experiment 1)
 Fifty female Std: ddY mice (4 weeks old) were used. After receiving a normal diet and
water ad libitum for 1 week, they were divided into two groups matched for body weight.
They were divided the sedentary and exercise group. These groups were fUrther
                                   97
subgrouped according to the normal diet group (e), high-fat diet group (-) and high-fat
diet plus astaxanthin (1.2 mglkg (A), 6 mgtkg (O)and 30 mglkg (D)).
Each value represents mean Å} SE. *,p < O.05; "Xi ,p < O.Ol, ***:p < O.O05 vs. high-fat.
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Fig. 4-2. Effects of astaxanthin and exercise on parametrial adipose tissue weight in
mice fed a hightat diet for 60 days (Experiment 1).
 Fifty female Std: ddY mice (4 weeks old) were used. After receiving a normal diet and
water ad tibitum for 1 week, they were divided into two groups matched for body weight.
They were divided the sedentary and exercise group. These groups were further
subgrouped according to the normal diet group, highifat diet group and high-fat diet plus
astaxanthin (1.2, 6 and 30 mglkg).
Each value represents mean Å} SE.
$:p < O.05, $$:p < O.Ol vs. high-fat (Sedentary).
##:p < O.Ol vs. high-fat (Exercise).
*:p < O.05.
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Fig. 4-3. Effects of astaxanthin and exercise on liver weight in mice fed a high-fat diet
for 60 days (Experiment 1).
 Fifty female Std: ddY mice (4 weeks old) were used. After receiving a normal diet and
water ad libitum for 1 weeK they were divided into two groups matched for body weight.
They were divided the sedentary and exercise group. These groups were imer
subgrouped according to the normal diet group, high-fat diet group and high-fat diet plus
astaxanthin (1.2, 6, and 30 mglkg).
Each value represents mean Å} SE.
$:p < O.05, $$:p < O.Ol vs. high-fat (Sedentary).
#: p < O.05, ##:p < O.Ol vs. high-fat (Exercise).
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Fig. 4-4. Effects of astaxanthin and exercise on plasma triglyceride in mice fed a
hightat diet for 60 days (Experiment 1).
 Fifty female Std: ddY mice (4 weeks old) were used. After receiving a normal diet and
water ad libitum for 1 week, they were divided into two groups matched for body weight.
They were divided the sedentary and exercise group. These groups were imher
subgrouped according to the normal diet group, high-fat diet group and high-fat diet plus
astaxanthin (1.2,6and 30 mglkg). '
Each value represents mean Å} SE.
$:p < O.05, $$:p < O.Ol vs. high-fat (Sedentary).
#:p < O.05, ##:p < O.Ol vs. high-fat (Exercise).
*:p < O.05.
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Fig. 4-5. Effects of astaxanthin and exercise on plasma total cholesterol in mice fed a
hightat diet for 60 days (Experiment 1).
 Fifty female Std: ddY mice (4 weeks old) were used. After receiving a normal diet and
water ad libitum for 1 week, they were divided into two groups matched for body weight.
They were divided the sedentary and exercise group. These groups were further
subgrouped according to the normal diet group, high-fat diet group and high-fat diet plus
astaxanthin (1.2g, 6 and 30 mglkg).
Each value represents mean Å} SE.
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Fig. 4-6. Effects of astaxanthin and exercise on plasma glucose in mice fed a high-fat
diet for 60 days (Experiment 1).
 Fifty female Std: ddY mice (4 weeks old) were used. After receiving a normal diet and
water ad libitum for 1 week, they were divided into two groups matched for body weight.
They were divided the sedentary and exercise group. These groups were further
sub-grouped according to the normal diet group, high-fat diet group and highrfat diet plus
astaxanthin (1.2, 6 and 30 mglkg).
Each value represents mean Å} SE.
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Fig. 4-7. Effects of astaxanthin and exercise on plasma GOT and GPT in mice fed a
hightat diet for 60 days (Experiment 1).
 Fifty female Std: ddY mice (4 weeks old) were used. After receiving a normal diet and
water ad tibitum for 1 week, they were divided into two groups matched for body weight.
They were divided the sedentary and exercise group. These groups Were further
subgrouped according to the norinal diet group, high-fat diet group and high-fat diet plus
astaxanthin (1.2, 6 and 30 mglkg).
Each value represents mean Å} SE.
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Fig. 4-8. Effects of astaxanthin and exercise on liver triglyceride in mice fed a high-fat
diet for 60 days (Experiment 1).
 Fifty female Std: ddY mice (4 weeks old) were used. After receiving a normal diet and
water ad libitum for 1 week, they were divided into two groups matched for body weight.
They were divided the sedentary and exercise group. These groups were further
subgrouped according to the normal diet group, high-fat diet group and high-fat diet plus
astaxanthin (1.2, 6 and 30 mglkg).
Each value represents mean Å} SE.
$$: p < O.Ol vs. highifat (Sedentary).
#: p < O.05, ##: p < O.Ol vs. high-fat (Exercise).
*:p < O.05, **:p < O.Ol.
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Fig. 4-10. Effects of astaxanthin and exercise on epididymal adipose tissue weight in
mice fed a hightat diet for 60 days (Experiment 2).
 Fifty male Std: ddY mice (4 weeks old) were used. After receiving a normal diet and
water ad tibitum for 1 week, they were divided into two groups matched for body weight.
They were divided the sedentary and exercise group. These groups were further
subgrouped according to the normal diet group, high-fat diet group and high-fat diet plus
astaxanthin 6 mglkg.
Each value represents mean Å} SE.
$:p < O.05, $$$:p < O.O05 vs. high-fat (Sedentary).
#:p < O.Ol, ###:p < O.O05 vs. high-fat (Exercise).
*:p < O.05.
107
O.05 i
 **
- Sedentary
O Exercise
O.04
Atu
g O.03
s
•ff
.2 e•o2
A
O.Ol
i
:
t
a
l
l
'
L
$ $
              i
            o L..
                  Normal diet Hightat diet Hightat+ As taxanthin
                                                   6 mgtkg
Fig. 4-11. Effects of astaxanthin and exercise on liver weight in mice fed a high-fat
diet for 60 days (Experiment 2).
 Fifty male Std: ddY mice (4 weeks old) were used. After receiving a normal diet and
water ad libitum for 1 week, they were divided into two groups matched for body weight.
They were divided the sedentary and exercise group. These groups were further
subgrouped according to the normal diet group, high-fat diet group and highifat diet plus
astaxanthin 6 mglkg.
Each value represents mean Å} SE.
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Fig. 4-12. Effects of astaxanthin and exercise on liver triglyceride in mice fed a
hightat diet for 60 days (Experiment 2).
 Fifty male Std: ddY mice (4 weeks old) were used. After receiving a normal diet and
water ad libitum for 1 week, they were divided into two groups matched for body weight.
They were divided the sedentary and exercise group. These groups were further
subgrouped according to the normal diet group, high-fat diet group and highifat diet plus
astaxanthin 6 mglkg.
Each value represents mean Å} SE.
$: p < O.05, $$$:p < O.O05 vs. high-fat (Sedentary).
#: p < O.05, ###: p < O.O05 vs. high-fat (Exercise).
**:p < O.Ol.
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CHAPTER 5. Effects of astaxanthin on lipopolysaccharide-nduced
inflammation in vitro.
5-1. Introduction
      Organisms require oxygen for the efficient production of energy
except for those organisms that are especially adapted to live under anaerobic
conditions and have been developed for a long time. Thereby oxygen is
considered as essential for life, but also it is reported to be toxic because of
the process that unleashes the free radicals. Oxidative stress has been defined
as an increase in free radical production that results from tissue damage.
There are numerous potential sources of free radical production within the
body, and one of these sources is activated neutrophils (54). Cell continuously
produce free radicals and reactive oxygen species (ROS) as part of metabolic
processes. These free radicals are neutralized by an elaborate antioxidant
defense system consisting of enzymes such as catalase, superoxide dismutase,
glutathione peroxidase, and numerous nonÅínzymatic antioxidants, including
vitamins A, C and E, glutathione, ubiquinone, carotenoids and flavonoids.
Exercise can produce an imbalance between ROS and antioxidants which is
referred to as oxidative stress. Physical activity increases the generation of
free radicals in several ways. Two to 59o of oxygen used in the mitochondria
forms free radicals. As oxidative phosphorylation increases in response to
exercise, there will be concomitant increase in free radicals. Catecholamines
that are released during exercise can lead to free radical production. Other
sources of free radical increase with exercise include prostanoid metabolism,
xanthine oxidase, NADPH oxidase, and several secondary sources, such as
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the release of radicals by macrophages recruited to repair damaged tissue
(55-56).
     Dietary antioxidants may attenuate oxidative damage from strenuous in
various tissues. Aoi et al. reported that astaxanthin can attenuate
exercise-induced damage in mouse skeletal muscle and heart, including an
associated neutrophil infiltration that induces further damage (57).
     In the present study, we investigated the nitric oxide (NO) production in
RAW 264.7 cells treated with astaxanthin in vitro to clarify the
anti-infiammatory effect.
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5-2. Materials and Methods.
5-2-1. Cell culture and LPS Stimulation.
     Cells of the mouse macrophage cell line RAW264.7 were cultured in
DMEM medium containing 109o fetal bovine serum and maintained at 37 OC
in humidified incubator containing 59o C02. RAW264.7 cells were seeded
onto a 24 well plate (4 Å~105 cells/well) for experiments. The cells were
pretreated with 2.5, 5, 10 and 20 yM astaxanthin (Sigma, USA.) for 24 hours
and subsequently stimulated with 10 pg/mL of lipopolysaccharide (LPS) for
24 hours, unless otherwise stated. Astaxanthin was dissolved in O.059o
dimethyl sulfoxide (DMSO). For the control group, RAW264.7 cells were
cultured with O.05% DMSO alone. The effects of astaxanthin were compared
with those of N-nitro-L-arginine methyl ester (L-NAME). L-NAME showed
effective inhibitory activity in LPS-induced NO production by directly
blocking the NOS enzyme activity (1-2).
5-2-2. Measurement of nitric oxide (NO), tumor necrosis factor
-ec (TNF-oc) and prostaglandin E2 (PGE2).
     Nitrite, a stable oxidized product of NO, was measured by using Griess
regents. The culture supernatant (100 pL) was mixed with 100 pL of Griess
reagent for 10 minutes, and the absorbance at 550 nm was measured in
microplate reader. The concentration of nitrite in the samples was determined
with reference to sodium nitrite standard curve. The data represent the mean
of six determinations Å} SE.
     The levels of TNF-oc and PGE2 in the medium were measured by
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ELISA (R&D Systems) according to the manufacturer's instruction.
5-2--3. MTT assay for cell viability
     For determination of RAW264.7 cell viability,
3<4,5-dimethyl-2thiazolyl)-1,5- dipheny}-2Htetrazolium bromide (Wako)
was added of cell suspension for 24 hours, and the MTT formazan formed
was dissolved in acidic-2propanol. Optical density was measured with a plate
reader used at 600 nm. The optical density of the Formosan formed by
untreated cell was taken as 1009o .
5-2-4. Statistical analysis.
     The values were expressed as mean Å} SE. A Student's ttest was used to
assess the statistical significance of difference. P < O.05 was regarded as
significant.
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5-3. Results.
5-3-1. Effect of astaxanthin on NO production in LPSinduced RAW
264.7 cells.
     NO are produced by immune activated macrophages, and at
inflammatory site. I determined if astaxanthin influences the production of
NO by RAW 264.7 cells exposed to LPS. The cells accumulated nitrite, as a
stable oxidized product of NO, in the culture medium when stimulated with
LPS, astaxanthin inhibited NO production (Fig. 5-1).
     Astaxanthin did not decrease cell viability in RAW 264.7 cells when
these cells were incubated with 20 pM astaxanthin alone for 24 hours.
5-3-2. Effect of astaxanthin on TNF-oe concentration in LPSinduced
RAW 264.7 cells.
     The TNF-ot concentration induced by LPS approximately seven times
higher than in the control group. The TNF-oc concentration in the astaxanthin
group showed a tendency to decrease in dose dependent manner. Treatment
with astaxanthin significantly reduced TNF-oc concentration compared with
that in the LPS group (Fig. 5-2). Treatment with L-NAME significantly
reduced TNF-oc levels compared with those of the LPS group.
5-3-3. Effect of astaxanthin on PGE2 concentration in LPSinduced RAW
264.7 cells.
                                        '
     The PGE2 concentration induced by LPS was approximately three times
higher than in the control group. The PGE2 concentration in the astaxanthin
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group showed a tendency to decrease in conjunction with decreases in
astaxanthin concentration. Treatment with astaxanthin significantly reduced
PGE2 concentration compared with that in the LPS group (Fig. 5-3).
Treatment with L-NAME showed PGE2 concentration were no significant
differences from the LPS group.
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54. Discussion
     Intense exercise leads to production of reactive oxygen species, mainly
via the mitochondrial electron transport chain, xanthine oxidase, and
phagocytes (58). Exercise-induced ROS oxidize several targets such as
proteins, lipids, and DNA in these tissues, causing oxidative damage in
skeletal muscle, heart and liver (58).
 The present study, elucidate the effects of astaxanthin on the in vitro
production of inflammatory cytokines and mediators. We investigated the
effect of astaxanthin on LPS induced NO production and PGE2 and TNF-ot
levels in RAW 264.7 macrophage cell, with L-NAME as a positive control.
Astaxanthin decreased NO production in a dose dependent manner. Our
results indicate that the compound, even at the concentration of 20 pM, did
not change cell viability. Therefore, inhibition of LPS induced NO production
by astaxanthin was not the result of its cytotoxicity on the cells.
 TNF-oc is a pleiotropic cytokine produced principally by activa'ted
macrophages and monocytes and also has a major role in the nonspecific
resistance against various infectious agents (59, 60). The results of this study
indicate that astaxanthin decreased TNF-oc concentration in a dose dependent
manner. The results of TNF--oe inhibition by astaxanthin correspond to the
results of decreased NO production, with the application of astaxanthin.
     The mechanism of the NO-induced suppression of TNF synthesis in not
known. A potential link is PGE2. It has been reported recently that NO
activates cyclooxygenase enzymes and thereby leads to marked increase in
PGE2 production (61). A suppressive effect of PGE2 on TNF synthesis
through elevated cAMP levels has been convincingly demonstrated (62, 63).
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In the present study, astaxanthin suppressed the levels of LPS induced PGE2
and TNF-ct in a dose dependent manner.
     Lee et al. reported that astaxanthin suppressed the serum levels of NO,
PGE2, TNF-oc and IL-16 in LPS administrated mice, and inhibited NF-KB
activation as well as iNOS promoter activity in RAW 264.7 cells stimulated
with LPS (64). These results agree with our research results.
     In summary, we investigated the NO production in RAW 264.7 cells
treated with astaxanthin in vitro to clarify the anti-inflammatory effect.
Astaxanthin decreased NO production in a dose dependent manner. Also,
astaxanthin suppressed the levels of LPS induced PGE2 and TNF-oc in a dose
dependent manner. A possible mechanism for the ocular anti-inflammatory
effect of astaxanthin is the suppression of production of NO, TNF-oc and
PGE2 by directly blocking NOS enzyme activity. These results suggest that
astaxanthin may attenuate exercise induced damage by downtegulating the
inflammatbry response.
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Fig. 5-1. Effects of astaxanthin on NO production in LPS induced RAW 264.7 cells.
RAW 264.7 cells were pretreated with various concentrations of astaxanthin and L-NAME for 24 hours.
Astaxanthin and L-NAME pretreated RAW 264.7 cells were incubated with LPS for 24 hours. The
nitrite concentration in the culture supernatants was determined for NO production. RAW 264.7 cells in
the control group were cultured with O.Ol 9o DMSO.
Each value represents mean Å} SE (n = 7).
":p < O.05, *":p < O.Ol compared with the LPS group.
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Fig. 5-2. Effects ef astaxanthin on cell viability in LPS induced RAW 264.7 cells.
RAW 264.7 cells were pretreated with various concentrations of astaxanthin and L-NAME
for 24 hours. Astaxanthin and L-NAME pretreated RAW 264.7 cells were incubated with
LPS for 24 hours. The cell viability determined by MTT assay. RAW 264.7 cells in the
control group were cultured with O.Ol 9o DMSO.
Each value represents mean Å} SE (n = 7).
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Fig. 5-3. Effects of astaxanthin on TNF-a levels in LPS induced RAW 264.7 cells.
RAW 264.7 cells were pretreated with various concentrations of astaxanthin and L--NAME
for 24 hours. Astaxanthin and L-NAME pretreated RAW 264.7 cells were incubated with
LPS for 24 hours. RAW 264.7 cells in the control group were cultured with O.Ol 9o DMSO.
Each value represents mean Å} SE (n = 7).
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Fig. 5-4. Effects of astaxanthin on PGE2 levels in LPS induced RAW 264.7 cells.
RAW 264.7 cells were pretreated with various concentrations of astaxanthin and L-NAME
for 24 hours. Astaxanthin and L-NAME pretreated RAW 264.7 cells were incubated with
LPS for 24 hours. RAW 264.7 cells in the control group were cultured with O.Ol 9o DMSO.
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CHAPTER 6. General discussion
     Astaxanthin is one of the carotenoid pigment found in aquatic animals
and is present in many of our favorite seafoods including salmon, trout, red
seabream, shrimp, lobster and fish eggs (1-12). It is also present in birds such
as flamingoes and quails (1-2). In many of the aquatic animals in which it is
found, astaxanthin has several essential biological function including
protection against oxidation of polyunsaturated fatty acids, protection against
UV light effects, immune response, pigmentation, reproductive behavior and
improved reproduction (65). In addition, one of the most important properties
of astaxanthin is its antioxidant properties which has been reported to surpass
those of 6Åíarotene or even a{ocopherol (2). It has many highly potent
pharmacological activities, such as antioxidative activity (36), antitumor and
antiÅíancer effects (7), and anti-diabetic (8-10) and anti-inflammatory actions
(10-11).
     The present study was designed to examine astaxanthin as functional
foods for anti-fatigue and antiDbesity.
1) Effects of astaxanthin supplementation on exercise-induced fatigue in
mice.
2) Effects of astaxanthin in obese mice fed a high-fat diet.
3) Effects of astaxanthin and exercise; promoting energy metabolism and
suppressing body fat accumulation in mice.
4) Effects of astaxanthin and exercise on mitochondrial enzymes in mice.
5) Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro.
     Our data suggest that astaxanthin may have beneficial effects on
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endurance capacity. The administration of astaxanthin causes an increase in
utilization of fatty acids as an energy source, which spares glycogen.
     In this paper, I found that astaxanthin inhibits the elevations in body
weight and adipose tissue weight caused by a high-fat diet. In addition,
astaxanthin reduced liver weight, liver triglyceride, plasma triglyceride, and
total cholesterol. The combination of astaxanthin and exercise was more
effective for decreasing body weight, epididymal adiposetissue weight.
Moreover, mitochondrial enzyme activities were more increased by
combination of astaxanthin and exercise.
     These results suggest that intake astaxanthin, in combination with
exercise, might improve endurance by modulating lipid metabolism and could
potentially inhibit the development of obesity and metabolic syndrome and
associated lifestyle related disease.
     Cells continuously produce free radicals and reactive oxygen species
(ROS) as part of metabolic process, Exercise can produce an imbalance
between ROS and antioxidants which is referred to as oxidative stress.
                            ,
Dietary antioxidant supplements are marketed to and used by athletes as
means to counteract the oxidative stress of exercise. We investigated the NO
production in RAW 264.7 cells treated with astaxanthin in vitro to clarify the
anti-inflammatory effect. Astaxanthin decreased NO production in a dose
dependent manner. Also, astaxanthin suppressed the levels of LPS induced
PGE2 and TNF-oc in a dose dependent manner. A possible mechanism for the
ocular anti-inflammatory effect of astaxanthin is the suppression of
production of NO, TNF-oc and PGE2 by directly blocking NOS enzyme
activity. These results suggest that astaxanthin may attenuate exercise induced
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damage by downtegulating the inflammatory response.
     Obesity is characterized at the cell biological level by an increase in the
number and size of adipocytes differentiated from fibroblastic pre adipocytes
in adipose tissues. Adipose tissue also participates in the regulation of energy
homeostasis as an importat endocrine organ that secretes a number of
biologically active adipokines such as free fatty acid, adipsin, leptin,
plasminogen activator inhibitor-1, resistin, adiponectin, and TNF--ot. Fatty
acids and their metabolites regulate gene expression and immunological
pathways. Furthermore, obese individuals frequently have increased
circulating fatty acid concentrations, and localized inflammation in adipose
tissue may facilitate the systemic inflammation associated with the insulin
resistance of obesity. Although palmitate induces inflammation (activates
proinflammatory pathways) in myotubes, the effects of fatty acids on
infiammatory processes in adipocytes have not been established. The potential
contribution of fatty acids to the mechanisms underlying impaired glucbse
metabolism has been described in the so called Randle effect (71). In addition,
fatty acids suppress insulinstimulated glucoce uptake in multiple cell types
(72), and it is well established that metabolic disorders, including
dyslipidemias, obesity, and diabetes, are often accompanied by elevated
serum concentrations of fatty acids (73). Because these disease are also
characterized by marked increases in serum concentrations of inflammatory
mediators, including TNF-S, interleukin 6 (IL-6), sialic acid, and C(eactive
protein (74-76), they are commonly referred to as inflammatory states (77,
78). Recent publications showed that palmitate induces insulin resistance in
myotube models (79, 80), and that the nuclear factor KB (NF-KB)
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transcription factor is a key mediator of this effect (81, 82). However,
insulin-induced glycogen synthesis and activation of Aktlprotein kinase B
(PKB) are not responsive to palmitate in 3T3-Ll adipocytes (79), but are
clearly suppressed by this fatty acid in myotubes (80). Therefore it is apparent
that the mechanisms underlying fatty acid-induced insulin resistance in
myofibers and adipocytes may differ, Adipose tissue is a major source of
proinflammatory cytokines, particularly in obesity (78). Considering this link
between obesity and adipose production of infiammatory mediators, it is of
great interest that lauric acid (72) and palmitate (81) induce cyclooxygenase-2
(COX--2) and IL-6 expression in macrophages and muscle, respectiveiy. Some
fatty acids also oppose insulin-mediated glucose uptake (83) and activate
inhibitor KB kinase (IKK) (84), the kinase that markes inhibitor KB (I KB) for
proteolytic degration to enable NF- KB function. Whether the same regulatory
linkages exist in the adipocyte has not been addressed experimentally. NF- KB
is a major inflammatory mediator in primary porcine adipocytes (85) and in
3T3-Ll adipocytes (86). Lee et al. reported that astaxanthin suppressed the
serum levels of NO, PGE2, TNF-ot and IL-16 in LPS administrated mice, and
inhibited NF-KB activation as well as iNOS promoter activity in RAW 264.7
cells stimulated with LPS (64). Moreover, astaxanthin blocked NF-KB p65
submit and I KBa degradation, correlated with its inhibitory effect on IKK
activity (64). These results and our results suggest that astaxanthin, probably
due to its antioxidant activity, inhibits the production of inflammatory
mediators by blocking NF- KB activation and as a consequent suppression of
IKK activity and IKB-ocdegradation. Consequently, inhibition of
inflammatory mediators by astaxanthin may regulate the adipocytokine in
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adipose tissue that is associated with obesity and insulin resistance.
     Astaxanthin has a strong quenching capability against damage from
singlet oxygen in vitro. It is reports that 80 times stronger than atocopherol
and twice as strong as 6tarotene (66). It is understandable why astaxanthin
has a strong singlet oxygen-quenching capability, and our research results,
considering its molecular structure. The reactivity to other molecular oxygen
decreases, because singletoxygenassociated, carbonÅíentered radicals of
astaxanthin can form more stable resonance structures by the attachment of
the carbonyl group and the hydroxyl group to the S-ionone ring of astaxanthin
(66). Astaxanthin can remove the chain carrying lipid peroxyl radicals in the
liposomal suspention more efficiently than 6Åíarotene but less efficiently than
orlocopherol, because the hydrogen bonds by the carbonyl group in 6-ionone
ring of astaxanthin and hydrophobic association by the polyene chain allows
astaxanthin to fu in the membrane phospholipid structure well (67-70). Thus,
these molecular structure and chemical forms of astaxanthin might be closely
related to metabolic and physiological functions attribute to astaxanthin.
     These results suggest astaxanthin as a promising natural candidate in
lifestyle related disease protection and in health promotion. Comprehensive
chemical, molecular biological and pharmacological research are required
determine the exact mechanism by which this astaxanthin affects anti-fatigue
and anti-obesity.
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